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8ABSTRACT
Peritonsillar abscess (PTA) is the most common deep head and neck infection. PTA 
is considered to be a purulent complication of acute tonsillitis (AT), although the 
correlation between these two has not been proven. In recent decades, infection of 
minor peritonsillar salivary glands has been proposed to be behind the development 
of PTA. Smoking has been known to predispose patients to PTA, and poor dental 
hygiene has been hypothesised to control the course of the disease.  
Clarifying the aetiology of PTA would help physicians differentiate better the 
subtypes of PTA and plan the best treatment for the patient. Diagnostic tools to achieve 
this are lacking. Diagnosis of PTA is clinical and is based on a patient’s symptoms and 
clinical examination. No blood tests or imaging has been used routinely. Bacterial 
culture is a slow method and is not used in clinical decision-making.
In the first study of this thesis, we compared bacterial findings of PTA between 
patients who had had a renewal and those who had not. Streptococcus anginosus 
group (SAG) was detected more often in the patients with renewal, compared to 
those without; however, no group A streptococcus was reported in patients with 
renewal. In addition, male patients over 40 years old had renewal episodes after a 
shorter period than other patients.
In the second study, we histologically analysed the presence of peritonsillar 
minor salivary glands and inflammation patterns from the removed tonsils. In 
most (67.5%) of the tonsil specimens, minor salivary glands were identified, and 
we observed a greater periductal inflammation in patients with PTA compared to 
AT and chronic tonsillitis groups. 
In the third study, we collected AT and PTA patients and found a subgroup 
of PTA patients without any clinical signs of AT. PTA patients without tonsillar 
findings had significantly lower C-reactive protein (CRP) levels than PTA patients 
with tonsillar findings. They were also older than other patients suffering from PTA.
In the fourth study, we compared salivary samples of the patients with AT, 
peritonsillitis, and PTA between themselves, and with healthy volunteers. No 
differences between groups were observed which could imply that the composition 
of oral bacterial microbiota may not have a significant effect on the development 
of PTA. Alcohol consumption, oral hygiene and smoking had no significant effect 
either on numbers or distribution of saliva bacteria.
Our studies suggest that tonsillar infection is not always a pre-stage of PTA and 
support the hypothesis that infection of minor salivary glands, in some cases, causes 
PTA. We also showed that SAG predicts renewal of PTA, and it is found in older 
male patients with rapidly proceeding disease. By understanding the aetiology of 
PTA better, we could also identify patients with different aetiological factors and 
target treatment more accurately. 
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Kurkkupaise on yleisin pään ja kaulan alueen syvä infektio. Perinteisesti kurk-
kupaisetta on pidetty akuutin nielurisatulehduksen märkäisenä komplikaationa, 
mutta tieteellistä näyttöä näiden kahden taudin yhteydestä ei ole. Viimeisten 
kahden vuosikymmenen aikana on tutkittu pienten peritonsillaarisesti sijaitsevi-
en sylkirauhasten roolia kurkkupaiseen taustalla.  Tupakan tiedetään altistavan 
kurkkupaiseen kehittymiselle, ja myös huonolla hammashygienialla saattaa olla 
vaikutusta taudinkuvan. 
Taudin etiologian tunteminen auttaisi kliinikkoa erottamaan taudin erilaiset 
alatyypit ja valitsemaan parhaan mahdollisen hoidon potilaalle. Kliinikot tarvit-
sisivat myös diagnostisia menetelmiä kurkkupaiseen aiheuttajan selvittämiseen. 
Kurkkupaiseen diagnoosi on kliininen ja perustuu potilaan oireisiin sekä lääkä-
rin suorittamaan tutkimukseen.  Verikokeita tai kuvantamistutkimuksia ei rutii-
ninomaisesti tarvita. Bakteeriviljelynäytteistä ei hoitoa suunniteltaessa ole hyötyä 
menetelmän hitauden vuoksi. 
Väitöskirjan ensimmäisessä osatyössä vertasimme kurkkupaiseiden märkäerit-
teen bakteerilöydöstä ”uusijoiden ja ei-uusijoiden” välillä. Streptococcus anginous 
–ryhmän (SAG) bakteereita tavattiin enemmän ”uusijoilla”, kun taas A-ryhmän 
streptokokkia (GAS) ei ”uusijoilla” todettu lainkaan. Lisäksi havaitsimme, että yli 
40 vuotiailla miehillä kurkkupaise uusii muita potilaita nopeammin.
Toisessa osatyössä mikroskopoimme histologisesti nielurisaleikkauksessa pois-
tettua peritonsillaari- ja nielurisakudosta, ja osoitimme, että valtaosalla potilaista 
(67.5%) on pieniä sylkirauhasia peritonsillaaritilassa. Lisäksi havaitsimme, että 
kurkkupaisepotilailla on pienen sylkirauhasen tiehyen ympärillä huomattavasti 
enemmän tulehdusta kuin niillä potilailla, joiden nielurisat on poistettu äkillisen 
tai pitkäaikaisen nielurisatulehduksen vuoksi.  
Kolmannessa osatyössä osoitimme ryhmän kurkkupaisepotilaita, joilla ei ollut 
merkkejä akuutista nielurisatulehduksesta. Havaitsimme, että kurkkupaisepotilail-
la, joilla ei havaittu nielurisoissa infektion merkkejä oli selvästi matalampi CRP-
arvo kuin potilailla, joiden nielurisoissa oli infektion merkkejä. Potilaat, joilla ei 
nielurisoissa havaittu tulehduksen merkkejä olivat myös selvästi vanhempia kuin 
muut kurkkupaisepotilaat.
Neljännessä osatyössä vertasimme terveiden vapaaehtoisten, äkillisestä nie-
lurisatulehduksesta, peritonsilliitista ja kurkkupaiseesta kärsivien potilaiden syl-
kinäytteitä. Ryhmien välillä ei havaittu eroja, joka voisi viitata siihen, ettei suun 
mikrobiston muutoksilla ole vaikutusta kurkkupaiseen kehittymiseen. Myöskään 
alkoholinkäytöllä, hammashygienialla tai tupakoinnilla ei havaittu olevan merkit-
tävää vaikutusta syljen bakteerien määrään. 
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Tutkimuksessamme osoitimme, ettei nielurisatulehdus aina edellä kurkkupai-
setta. Tutkimuksemme tukee vahvasti hypoteesia, jonka mukaan osa kurkkupai-
seista aiheutuu pienten sylkirauhasten tulehduksesta. Lisäksi osoitimme, että SAG 
ennustaa kurkkupaiseen uusiutumista ja on yleensä vanhempien miesten taudin-
aiheuttajana. Ymmärtämällä kurkkupaiseen etiologiaa voimme jatkossa paremmin 
tunnistaa eri etiologiset tekijät ja valita hoidon tarkemmin.
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SAMMANFATTNING
Peritonsillär abscess (PTA), också kallad halsböld, är den vanligaste djupa huvud- 
och halsinfektionen. PTA har traditionellt antagits vara en komplikation av akut 
tonsillit (AT) men en korrelation mellan AT och PTA har inte påvisats. I 20 års 
tid har man spekulerat att en del av halsbölderna kunde bero på en infektion i 
de små peritonsillara spottkörtlarna. Rökning ökar incidensen av PTA och dålig 
tandhygien kan också vara relaterad till sjukdomen.
Identifiering av etiologin för PTA hjälper läkaren att känna igen olika typer av 
PTA och välja den bästa behandlingen för patienten. Dessutom strävar vi efter 
att hitta diagnostiska verktyg för att åtskilja kausitiva faktorer av PTA. Diagnosen 
av PTA är klinisk och baserad på patientens symptom och klinisk undersökning. 
Rutinmässiga blodprov eller radiologiska undersökningar behövs inte. Varprov är 
inte nödvändigt för planering av vården eftersom metoden är långsam. 
I första studien av avhandlingen jämförde vi varprovens bakterier hos de pa-
tienter som återinsjuknat och de som icke återinsjuknat. Ingen av de återinsjuk-
nade patienterna hade grupp A Streptococcus i varprovet. Däremot observerades 
Streptococcus anginosus -gruppens bakterier oftare i den återinsjuknade gruppen. 
Över 40-åriga män återinsjuknar i PTA mycket snabbare och kraftigare än andra 
PTA-patienter.
I andra studien analyserade vi tonsillavävnadens histologi. Vi fann små spott-
körtlar i majoriteten (67,5%) av histologiska proven. Vi observerade också att pe-
riduktala inflammationen var betydligt starkare hos PTA-patienterna jämfört med 
AT- och CT-patienter. 
I tredje studien upptäckte vi en grupp av PTA-patienter utan tecken av infektion 
i tonsillerna. Dessa patienter hade lägre CRP och var äldre än PTA-patienterna 
med tecken av infektion i tonsillerna.
I fjärde studien jämförde vi salivprov av patienter med AT, PT och PTA patien-
ter sinsemellan och med friska referenspatienter. Vi observerade inga skillnader 
mellan grupperna, vilket kan tyda på att skillnaderna i salivbakterierna inte har en 
relevant inverkan på utvecklingen av PTA. Alkoholförbrukning, tandhygien eller 
rökning har ingen relevant inverkan på salivbakteriernas mängd  eller kvalitet. 
Vi visade att PTA inte alltid utvecklas som en komplikation av AT. Vår undersök-
ning stöder starkt hypotesen att en del av PTA utvecklas från en infektion i mindre 
spottkörtlarna. Ytterligare påvisade vi att SAG förutspår återinsjuknande I PTA och 
förorsakar vanligen äldre mäns PTA. Genom att känna igen PTA: s etiologi, kan vi 
i fortsättningen känna igen etiologiska faktorerna och välja vården noggrannare.
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INTRODUCTION
Peritonsillar abscess (PTA) is a frequent deep head and neck infection and the most 
common otorhinolaryngological (ORL) infection requiring tertiary medical care 
[1, 2]. PTA is defined as a collection of pus usually located between the tonsillar 
capsule and pharyngeal constrictor muscles near the tonsil´s superior pole [3, 
4]. Almost 800 patients suffering from PTA are treated in Helsinki University 
Hospital (HUH), Department of ORL, annually. PTA is seen in all ages from infants 
to very old people. Depending on age, duration of symptoms, cooperation, and 
general overall health, treatment varies from an incision on an outpatient visit to 
a tonsillectomy (TE) and hospitalisation.  The complications of PTA can be severe 
and require treatment in the intensive care unit (ICU) which consumes expensive 
resources. All patients also need sick leave, which further burdens the society. [2]. 
Therefore, it is important to treat the patients with PTA in the most accurate and 
efficient way from the baseline. 
Despite its high incidence, the aetiology of PTA is controversial. Traditionally 
PTA is classified as a complication of acute tonsillitis (AT). No scientific evidence, 
however, supports this theory [3]. A presumption was raised over two decades ago 
that the development of PTA could be associated with an infection of minor salivary 
glands, more accurately Weber’s glands [3, 4]. Few small, uncontrolled studies 
have shown that the minor salivary glands are infected in patients with PTA [4-7]. 
An Egyptian study group has observed that amylase levels in pus and serum are 
elevated in PTA patients compared to patients with other neck or oral abscesses 
[8, 9]. Salivary amylase levels can be used as a marker about salivary function [10]. 
Recently a large cohort study showed that the incidence of AT increases during 
the winter, while the incidence of PTA is steady throughout the year. This finding 
does not support that PTA is only a complication of AT.[11]. 
Though PTA is traditionally regarded as a complication of tonsillitis, it is possible 
that poor oral hygiene, patients´ characteristics like age and gender, smoking, and 
infection of minor salivary glands play a role in aetiology of PTA [3, 12, 13]. These 
patients with different subtypes of PTA should be recognised and treatment should 
be targeted based on the aetiology in the future. In this doctoral thesis, we aim to 
specify the diverse aetiology of PTA and find diagnostic tools to differentiate the 
subgroups of PTA patients with different causative agents.
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1 REVIEW OF LITERATURE
1.1 Anatomy and histology of tonsils and salivary 
glands
1.1.1 Tonsils
The palatine tonsils are located in the lateral part of the oropharynx surrounded by 
the palatoglossal muscle anteriorly and the palatopharyngeal muscle posteriorly. 
Laterally the tonsil is covered by a fibrous connective tissue capsule. Tonsillar 
crypts on the medial surface are formed of non-keratinised stratified squamous 
epithelium. The number of tonsillar crypts varies from 8 to 20 in one tonsil. Palatine 
tonsils are a major component of lymphoid tissue which forms Waldeyer’s ring. 
Other components are adenoid, lingual and tubal tonsils. The main function 
of Waldeyer’s ring is to act as a first line of defence against pathogens. [4, 14]. 
Interaction between pathogens and tonsillar lymphocytes happens via apertures 
of tonsillar crypts [4, 15, 16]. 
Uvula
Palatoglossal arch, 
anterior pillar
Palatine tonsil 
(infected)
Palatoglossal arch, 
posterior pillar
Figure 1. Anatomy of oropharynx.
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1.1.2 Minor salivary glands
There is a group of 20 to 25 mucous salivary glands located in the superior 
peritonsillar space [5]. In this thesis minor salivary glands means minor peritonsillar 
salivary glands. The precise location of peritonsillar-located minor salivary glands is 
reported in few uncontrolled studies. These studies have shown that minor salivary 
glands appear at the upper, middle, and lower portions of the peritonsillar space 
outside the tonsillar capsule. However, only glands located in the superior pole 
are called Weber´s glands, described by German anatomist Moritz Ignaz Weber 
in 1927. [4, 5, 7]. Minor salivary glands are organised in small lobules and send 
the common ducts from the glands to the tonsillar crypts penetrating the tonsillar 
capsule on the way [4]. In histological analysis of PTA patients’ tonsillar tissue, 
the inflammation and fibrosis of minor salivary glands has been observed [6, 7].
1.1.3 Major salivary glands
The paired parotid, submandibular, and sublingual glands comprise the major 
salivary glands. The parotid gland becomes inflamed most commonly. Acute and 
chronic sialadenitis, viral infections, and various neoplasms are the most common 
diseases of major salivary glands. [17, 18].
1.2 Acute tonsillitis (AT)
Acute tonsillitis (AT) is one of the most common upper respiratory infections 
in primary health care [19]. It affects both children and adults and the highest 
incidence is in those from 5 to 15 years of age [3, 11, 20, 21].  
The diagnosis is clinical and the typical symptoms include sore throat, fever, and 
difficulties swallowing. In clinical examination a physician can detect pharyngeal 
erythema with or without tonsillar exudates and painful cervical adenopathy. 
The raised inflammation markers as C-reactive protein (CRP) and leukocytes in 
laboratory tests may be linked to the higher likelihood of streptococcal infection; 
however, routinely laboratory tests (CRP, total blood count, and electrolytes) are 
recommended only to those patients who require hospital admission. [20]. Based 
on signs and symptoms, it is impossible to differentiate causative agents. Accuracy 
in differentiating clinically virus from bacteria or group A Streptococcus (GAS) 
versus non-GAS is weak [20, 22]. Finnish Current Care Guidelines recommend 
trying to find GAS as a causative agent. [23]. Because culturing the bacteria is 
too slow for decision-making, rapid antigen detection tests (RADT) with high 
specificity (95%) and quite high sensitivity (70 to 90%) are nowadays widely used 
17
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in emergency departments for detecting GAS [24]. There are also point-of-care 
tests for detecting mononucleosis in clinical use [25].
50–80% of ATs are caused by viruses. The most common viruses causing AT 
are rhinoviruses, coronaviruses and parainfluenza viruses. GAS, Fusobacterium 
necrophorum (FN), and other betahaemolytic streptococcus are the most common 
bacteria causing AT and they are associated with 5–36% of tonsillar infections. 
Other bacteria found from bacterial culture of AT patients are Staphylococcus 
aureus, Chlamydia pneumoniae, Mycoplasma pneumoniae, Haemophilus 
influenzae, Candida spp., Neisseria meningitidis, Yersinia enterocolitica, 
Arcanobacterium haemolyticum, and Neisseria gonorrhoeae. [20, 23]. The 
possibility of Corynebacterium diphtheriae as a causative agent of AT should 
remembered in patients with severe course of disease [26].
Antibiotic use for tonsillitis is controversial. The treatment of viral tonsillitis 
is mainly conservative; however, severe cases of bacteria-caused tonsillitis are 
treated with aggressive antibiotic administration and hospital admission. The level 
of evidence for antibiotic treatment of AT is highest in GAS tonsillitis. Antibiotic 
treatment can modestly relieve the symptoms and reduce the duration of symptoms. 
Penicillin is regarded as the first-line antibiotic for GAS tonsillitis. A single-dose 
corticosteroid has also been shown to relieve the pain. [20, 23]. 
The most common complications of AT are other bacterial infections, such as 
PTA, invasive GAS disease, and retro- and parapharyngeal abscesses. The incidence 
of bacterial complications of AT does not correlate with the antibiotic use targeted 
to AT. [27]. Lemierre´s syndrome is a rare complication of FN tonsillitis [28].  
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1.3. Chronic tonsillitis (CT) 
Chronic tonsillitis (CT), more specifically chronic caseous tonsillitis (CCT), is the common cause of 
sore throat and halitosis (clinically detectable or non‐detectable odour). CT occurs in both genders 
and at any age. In CT, tonsillar stones, also called tonsilloliths, are formed when the mineralised 
debris of food, leucocytes, and bacteria are trapped in the tonsillar crypts. About 77% of CT patients 
suffer from halitosis. Symptomatic CT is treated with topical antiseptics, per oral antibiotics, and in 
the end with TE if clinical treatment does not bring the relief. [29, 30].  
 
Figure 2. Acute tonsillitis.
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1.3 Chronic tonsillitis (CT)
Chronic tonsillitis (CT), more specifically chronic caseous tonsillitis (CCT), is the 
common cause of sore throat and halitosis (clinically detectable or non-detectable 
odour). CT occurs in both genders and at any age. In CT, tonsillar stones, also 
called tonsilloliths, are formed when the mineralised debris of food, leucocytes, and 
bacteria are trapped in the tonsillar crypts. About 77% of CT patients suffer from 
halitosis. Symptomatic CT is treated with topical antiseptics, per oral antibiotics, 
and in the end with TE if clinical treatment does not bring the relief. [29, 30]. 
1.4 Recurrent tonsillitis (RT)
In literature, recurrent tonsillitis (RT) is usually defined as recurrent acute episodes 
of tonsillitis, but the number of AT episodes is not specified. Chung et al. used 
a minimum of five episodes in the past year as a limit to the definition of RT 
[31]. To Kronenberg et al. two episodes confirmed by physician was enough to 
be categorized RT [32]. In Finnish Current Care Guidelines RT is defined as a 
minimum of 4 episodes in a year or three episodes in half a year [23]. In some 
studies, the number of episodes has not even been defined [33, 34] . 
The percentage of PTA patients with a history of recurrent episodes of AT varies 
from 8% to 60% [31, 33-36]. Changes can be explained by the different definitions 
of RT. Tachibana et al. showed that patients with RT before PTA recover faster. 
They speculated that previous throat infections would cause adhesion around the 
tonsil which in turn could prevent the abscess from spreading. [36]. Opposite 
results have also been reported [35].
1.5 Sialadenitis of major salivary glands
The development of acute sialadenitis has been described as a process in which 
stasis of the salivary duct permits retrograde bacterial flow from the oral cavity 
into the gland. The most common bacteria causing acute bacterial sialadenitis 
are some of the same bacteria met in AT and PTA: GAS, Staphylococcus aureus 
and Haemophilus influenzae. Poor dental hygiene has also been connected to 
development of acute sialadenitis. [18, 37, 38]. In the majority of patients suffering 
from parotitis, elevated serum amylase (S-Amyl) levels have been registered but 
only a few patients have demonstrated elevation of CRP [37, 39].
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1.6 Epidemiology of PTA
PTA is the most common deep neck infection in ORL. Usually its incidence is 
highest in teenagers and young adults equally in both genders. PTA develops more 
often in the left side and its recurrence rate is between 9% and 22%. 
1.6.1 Incidence
PTA´s incidence is 10–41/100,000 [2, 3, 21, 27, 40-42]. The large variation 
in reported incidences has been thought to be connected to the number of 
tonsillectomies (TE) in the country. Low frequency of TEs, aspiration and incision 
and drainage (ID) of the abscess is linked to higher incidence of PTA. [2, 43, 44]. 
1.6.2 Age
Median age of PTA patients is 25–26 years [21, 34, 45]. The incidence of PTA is 
higher in teenagers and young adults, gradually decreasing after age 40 until old 
age [21, 34, 41]. In children the reported incidence is 18/100,000 [44]. Patients 
older than 40 years have a lower incidence of throat infections and also a lower 
probability of recurrence of PTA [32]. One possible explanation for PTA’s higher 
incidence in young adults is their higher smoking rate [46, 47]. According to Marom 
et al. the incidence among elder patients is, however, increasing [48]. 
PTA in elder patients differs in many ways from PTA in young adults. Older PTA 
patients have a longer hospital stay. The rate of complications and comorbidities 
is higher among the older patients. Older patients have also worse oral hygiene. 
[35, 48]. 
1.6.3 Gender
Between the ages of 10 and 14, girls suffer from PTA more often than boys. After 
that until at least the age of 70, men predominate significantly over women [21, 
41, 43]. These observation are probably due to changes in the immune system 
during puberty [21]. In adults the male to female ratio is reported to be between 
1:1 and 2:1[21, 33, 40, 49-51]. Male predominance may be partly a result of the 
higher incidence of smoking in males. When the effect of smoking is observed and 
excluded, the risk of PTA is still 9.5% higher among males [46]. 
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1.6.4 Side
Left predominance in PTA formation has been reported in several studies and it is 
found in both genders [33, 48, 50]. The cause of this slight asymmetry is unclear. 
It has also been proposed that it could be a coincidence [52]. Bilateral abscesses 
are rare, with only 0.2–1.8% of PTA patients [35, 36, 48].
1.7 Clinical characteristics of PTA
1.7.1 Location of peritonsillar abscess (PTA)
PTAs are nearly always (64–99%) located at the superior part of peritonsillar 
space. However, inferior and middle abscesses have also been described [5, 13, 28, 
31, 53]. PTA is usually, with very few exceptions, unilateral [13, 35]. Even though 
rare, PTA has also been diagnosed in patients with no tonsil tissue left after TE 
[54]. Intratonsillar abscess (ITA) is a different disease and, compared to PTA, is 
extremely rare [28].
Peritonsillar 
abscess
Figure 3.  Peritonsillar abscess.
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1.7.2 Recurrence of PTA
Recurrent PTA is defined as the recurrence of abscess formation at the same site 
after the initial treatment. No conclusion about the required time period after 
the first PTA exists. Several studies have used 0 to 2 months as an interval after 
the primary PTA period [31, 32, 49, 55]. Bovo et al. showed that most relapses of 
PTA happen during the first three months after the first PTA episode [41]. When 
treated with ID, recurrence rate after a single PTA episode is between 9–22% [2, 
32, 41, 49, 50, 55, 56]. After the second and third PTA episodes, the risk of further 
recurrences increases [31, 41]. Increased recurrence rate has also been observed 
in patients with RT and patients with FN in bacterial culture. Jousimies-Somer 
observed also SAG predicted renewal, while in contrast GAS was rare in PTA 
patients with a renewal [31, 32, 57]. Spreading to extraperitonsillar space also 
predicts recurrence [31].
In a Finnish study, most (65%) recurrences occurred after 3 days, with a 
range of 1–42 days. No difference emerged between penicillin + metronidazole 
and penicillin + placebo groups or in subgroups observed by age, gender, pre-
admission antibiotics, smoking, success of the primary opening, or the time point 
of recurrence. [55]. In another study, a significant male predominance in patients 
with RT was observed, but smoking had no effect on recurrence [48]. Gavriel et al. 
have, on the other hand, shown that anaerobic bacterial growth correlates with the 
higher recurrence rate [58]. Asthma and diabetes mellitus type 2 have also been 
associated with a readmission to hospital, but the reason for the readmission was 
not analysed more precisely [49]. 
1.7.3 Complications of PTA
Complications after PTA are uncommon, with an incidence of 3%. Complications 
are, however, potentially life-threatening [48]. Complications include the infection 
spreading into the parapharyngeal space and other deep neck spaces. These patients 
require inpatient treatment, intravenous (IV) antimicrobial therapy, and sometimes 
also monitoring in the ICU. [48]. Aspiration, airway obstruction, erosion into major 
blood vessels, Lemierre´s syndrome, or extension to the mediastinum are the 
known complications of PTA and are potentially fatal [2, 28, 49]. Possible fatal 
complications have been seen in 0.41% of cases [41]. 
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1.8 Aetiology of PTA
Aetiology of PTA is controversial. The condition is usually believed to be the 
continuum of AT via peritonsillitis to the formation of an abscess. However, 
an abscess can develop without any preceding history of tonsillitis. [28]. That 
has raised the other main theory to explain the formation of PTA: infection of 
peritonsillar minor salivary glands [4]. In recent decades, the aetiology of PTA 
has been speculated on, but no consensus exists. 
1.8.1 Theory of minor salivary glands causing PTA
Minor salivary glands are localised at the upper, middle, and lower portions of the 
peritonsillar space [5]. Inflammation and fibrosis of minor salivary glands has been 
observed in PTA patients [6, 7]. The scarring and obstruction of the draining ducts 
of minor salivary glands could promote the formation of PTA [28]. El Saied et al. 
showed that both serum and pus amylase levels are highly elevated in patients 
with PTA, compared to levels seen in those with deep neck abscesses and dental 
abscesses [8, 9]. PTA recurrence is more likely in patients with RT. This could 
be due to scarring or other anatomic changes in the minor salivary gland.  [13, 
31]. PTA has also been diagnosed in patients who have undergone TE, but these 
patients are a small minority [54].
AT is usually bilateral, while PTA is nearly always unilateral [28]. In the vast 
majority of cases (64-99%) PTA is located in the supratonsillar space of the 
oropharynx. This supports the theory of the infection of small salivary glands 
because most of the glands are found in the same location [4, 13, 54]. Kordeluk 
et al. also showed that although the incidence of AT increases during the winter, 
the incidence of PTA remains the same the whole year, so there is no seasonal 
correlation between the incidence of AT and PTA [11]. Other studies in different 
countries have produced the same results [59, 60]. 
1.8.2 Theory of AT causing PTA
AT has traditionally been regarded as the only cause of PTA. The disease process 
has been explained as pathogens spreading from the tonsils to peritonsillar space. 
Development of PTA starts in the intratonsillar fossa, which is situated between the 
upper pole and the body of the tonsil, and eventually extends around the tonsil. [6, 
13, 28]. The theory does not explain, however, how the causative agents penetrate 
the tonsillar capsule [13].
Same major pathogens of AT and PTA are found from the pus aspirates and 
bilaterally tonsillar tissue [13, 47, 61]. In some studies, antimicrobial treatment had 
a minor preventative effect on the developing of PTA in certain subgroups. There 
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are, however, also studies where the difference has not been shown. [3, 5, 13, 47, 
62, 63]. Recently, a large Swedish study demonstrated an even lower rate of PTA 
after AT in case where the patients were not treated with antibiotics during an AT 
episode [27]. Marom et al. showed that 66.2% of patients developed PTA in spite of 
prior antimicrobial therapy [48]. They also found that as many as 79% of patients 
reported a sore throat episode preceding PTA [34, 48]. In a recent review, Little et 
al. found that some PTA patients had had a sore throat episode one month before 
developing PTA and the researchers have interpreted this as support to the AT 
hypothesis. In addition, they also found that tonsillar inflammation during a sore 
throat episode predicts complications. Complications were, however, analysed in 
large groups of diseases, and subgroup analysis of PTA was not introduced in the 
primary study. [13, 64].
1.8.3 Smoking
Smoking is associated with increased risk to PTA in both genders. As many as 30% 
to 60% of patients with PTA have reported daily smoking which is significantly 
higher than the smoking rate in the general population. In Finland the number 
of daily smokers in the general population is 13%. [36, 46, 48, 49, 65, 66]. Also, 
the number of ex-smokers among PTA patients is high: 18% [49].  The specific 
mechanism of how smoking promotes these diseases is not clear. Klug et al. 
found no differences in PTA pathogens between smokers and nonsmokers [46]. 
In another study, smokers with PTA were observed to have a higher incidence 
of Streptococcus viridans (includes SAG) isolates in microbiological cultures of 
pus samples [48]. Torre et al. showed histological changes in both lymphoid and 
non-lymphoid compartments of tonsils in smokers. Changes in immune defence 
mechanisms via changed cell-to-cell or cell-to-matrix interactions in tonsillar 
tissue could be one possible mechanism explaining how smoking induces PTA. 
[67]. Among invasive pneumococcal diseases, Nuorti et al. have observed that 
smoking seems to be the most important risk factor among immunocompetent, 
non-elderly adults. They speculated that the higher rate of bacteria carriers among 
smokers, poor mucociliary clearance, or enhanced bacterial adherence could be the 
possible biological mechanisms enabling smoking to promote the development of 
pneumococcal disease. These same mechanisms could expose smokers to tonsillar 
diseases. [68]. Smoking alters the composition of subgingival bacterial microbiota 
in the development of periodontal disease and increases the depth of periodontal 
pockets [69, 70]. Although smokers have significantly higher CRP levels during 
PTA episodes, no difference in leukocyte or neutrophil levels has been shown. 
Klug et al. did not notice any difference in the duration of symptoms between 
smokers and nonsmokers. [46]. Correlation between smoking and postoperative 
haemorrhage has also been studied but no correlation was found [66].
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1.8.4 Periodontal disease
Periodontal diseases, the group of chronic inflammatory diseases of gingiva, 
supporting connective tissue, and alveolar bone, can be regarded as a public 
health concern when it affects as much as 20–50% of the global population in 
both developed and developing countries. Periodontal diseases are speculated to 
be an aetiological factor of PTA. [12, 71]. Georgalas et al. showed that patients with 
PTA have considerably more periodontal diseases than patients with CT [12]. Like 
PTAs, oral infections are also typically polymicrobial. Same bacterial species, such 
as Prevotella spp., and Fusobacterium spp., have been identified in not only PTA 
but also periodontitis and in the tonsillar area [3, 5, 12]. The causality between 
these two diseases has, however, not been shown although the changes in oral 
microbiota have been speculated to participate in this process. It is known that low 
socioeconomic status, smoking, and diabetes are associated with upper respiratory 
infections. Poor oral hygiene has also been thought to be linked to these other 
factors and not be an individual causative factor. [3, 12, 72]. 
1.8.5 Other possible factors
Several host factors may also promote PTA, such as compromised immunity and 
previous use of antibiotics. There are, however, no studies about these topics in 
the scientific literature. [12]. Recently a Korean research group published a study 
suggesting that air pollutants (with high concentration of NO2 and PM10 ) could 
be the risk factor for PTA [73].
1.9 Diagnosis and differential diagnosis of PTA
Diagnosis of PTA is usually clinical and is based on patient’s symptoms, careful 
clinical examination performed by a physician, as well as aspiration or ID of PTA. 
Routinely no laboratory tests or imaging are needed. [2].
1.9.1 Signs and symptoms of PTA
The common symptoms of PTA are sore throat, difficulties and pain in swallowing, 
trismus, and fever [1, 51, 74, 75]. Duration of symptoms before diagnosis is usually 
2–6 days. [1, 21, 33, 40, 45, 48, 55]. The duration of symptoms in older patients 
is twice as long as in younger patients and they seldom suffer from fever or 
trismus [76]. In an ORL examination a physician may observe tonsillar exudates, 
asymmetric peritonsillar swelling, uvular deviation, and enlarged cervical lymph 
nodes [6, 28, 33, 51, 74, 77]. Patients over age 40 with no history of RT and high 
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CRP can be regarded as a risk group, with a longer recovery time than other PTA 
patients [36].
1.9.2 Diagnostic tools in PTA
Traditionally diagnosis of uncomplicated PTA has been clinical, and neither 
laboratory tests nor imaging has been considered necessary [2, 28]. Diagnosis is 
based on finding the abscess from peritonsillar space with aspiration or ID [31]. 
A recent review, however, recommended that CRP and full blood count should 
be taken from all PTA patients, but the benefits of laboratory tests in diagnosis or 
treatment of PTA are poorly evidenced. Because dehydration is a common symptom 
of PTA, electrolytes were also recommended to be analysed. [2]. Tachibana et 
al. have shown that serum leukocytes are higher in patients with PTA than in 
patients with AT. Differences in CRP levels were not observed between groups. The 
researchers, however, noted that high CRP is associated with longer recovery time 
and predicts a slower healing process after PTA. [36, 78]. In a study by Johnston 
et al., median serum CRP in all PTA patients was 85mg/l (range: 41–143 mg/l) 
[49]. PTA caused by FN is noted to increase CRP and neutrophil levels significantly 
more than PTA caused by other pathogens [40]. Salivary amylase levels can be 
used as a marker of salivary function [10]. El Saied et al. showed that both serum 
and pus amylase levels are highly elevated in patients with PTA, compared to 
levels in patients with deep neck abscesses and dental abscesses (PTA patients: 
mean S-Amyl 50 U/l, mean pus amylase 3045 U/l, range 20–11,000 U/l) [8, 9].
Computed tomography imaging can be used when extraperitonsillar spread 
is suspected. Another indication for computed tomography imaging is trismus, 
when a patient is unable to open his or her mouth for clinical examination. [28, 
31, 49]. The use of CT in PTA diagnostics has increased in recent years, due to 
decreased costs and radiation doses as well as better availability of the imaging 
[44]. Intraoral ultrasound can be used to confirm the presence of an abscess as 
well as its volume, location, and relationship to the carotid artery. Ultrasound has 
an 89–95% sensitivity and a 79–100% specificity for diagnosing PTA [2, 28, 79].
Bacteriologic cultures are not useful in non-complicated cases of PTAs, as the 
bacteriological results often delay, and the timing of the results does not match the clinical 
need. They should be used, however, in patients with a high likelihood of infection 
by atypical or antimicrobial-resistant organisms—for example, in patients with a 
poor response to treatment, in diabetics, in immunocompromised patients, and 
in patients with a recurrent PTA [51].
26
Enni Sanmark & Née Kaltiainen
1.9.3 Peritonsillitis (PT)
Making a differential diagnostic between peritonsillitis (PT), also called peritonsillar 
cellulitis, and PTA is not always easy. The differential diagnosis is mainly based on 
pus aspiration. [21, 41, 77, 80]. The aetiology of PT is as unclear as PTA’s. PT could 
be the same disease as PTA with the same causative agents, only at an earlier stage, 
but the association of these two diseases has not been shown in the literature. The 
signs and symptoms of PT are like those of PTA, but without a confirmed abscess 
formation. Patients’ characteristics and symptoms between PT and PTA patients 
have been compared in a study by Risberg at al. The median age of patients, days 
of sore throat, amount of prior antibiotics, mean duration of prior treatment, and 
percentage of tested GAS were all equal. [45]. 
1.9.4 Mononucleosis
Mononucleosis is a possible differential or co-diagnosis of both AT and PTA [2]. 
Approximately 1 to 10% of AT cases are caused by mononucleosis, more specifically 
an infection caused by Epstein-Barr virus (EBV) [20]. Retrospectively diagnosed 
simultaneous mononucleosis is found in 1.5%–6% of patients with PTA. Incidence 
of mononucleosis is higher in teenagers and young adults, and a mononucleosis 
test is therefore recommended in unclear cases, especially for teenagers and young 
adults. [2, 49, 81]. PTA patients with simultaneous mononucleosis have lower 
leukocyte levels than PTA patients without mononucleosis [40].
1.9.5 Retro- and parapharyngeal abscess
Retro- and parapharyngeal abscesses share similar clinical characteristics with PTA 
and are sometimes difficult to distinguish from PTA. Retropharyngeal abscesses 
occur in children while parapharyngeal abscesses affect primarily adults [17]. The 
annual incidence of parapharyngeal abscesses is 0.9/100,000. As many as 50% of 
patients with parapharyngeal abscess have a concomitant episode of PTA. [28, 82]. 
Parapharyngeal abscess is treated with abscess tonsillectomy or external drainage 
and IV antibiotics. Difficulties in breathing and limited range of motion of neck 
are associated with retropharyngeal and parapharyngeal abscesses, usually not 
PTA. The trismus is a common symptom of both PTA and retropharyngeal and 
parapharyngeal abscesses. [28, 83]. 
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Parapharyngeal 
abscess
Figure 4. Parapharyngeal abscess.
1.9.6 Intratonsillar abscess (ITA)
ITAs are rare [17, 28]. They are defined as a collection of pus in the parenchyma of 
the tonsil. As in PTA, the pathogenesis of ITA is also uncertain. Two mechanisms 
of the formation of ITA have been proposed. Firstly, direct invasion of pathogens 
into the tonsillar crypts is followed by enlargement of the inflamed tonsil, which 
causes occlusion of the crypt. Secondly, bacterial seeding via the bloodstream or 
lymphatic system leads to abscess formation inside the tonsil. [6, 16].
1.10 Microbiology and the most important pathogens in 
tonsillar infections
In the literature, microbiological findings show large variability. This could result 
from the existing variations in handling, culturing methods, or differences in 
advanced technology. Because of this, the studies are only partly comparable.
The microbiology of abscesses is generally related to microbiota of the originating 
focus. In this thesis microbiota means mainly bacterial microbiota. That’s why 
microbiology of PTA and other deep neck abscesses is similar, reflecting the host’s 
oropharyngeal microbiota. [17, 28]. There is no consensus in literature whether 
a PTA is monobacterial or polybacterial infection. Variation in the results can be 
explained with different collection methods, culture techniques, and incubation 
times in different studies. [3, 28, 50, 84, 85]. The amount of positive bacteria culture 
samples in PTA patients is between 48% and 100% depending on culture methods 
28
Enni Sanmark & Née Kaltiainen
and incubation time [34, 40, 48, 51, 84, 85]. Microbiota may also differ because 
of a patient´s diet and lifestyle [3, 28, 84, 85]. There is no consensus in literature 
about the impact of prior antibiotic treatment of AT or PTA on microbiota. Sakae 
et al. found no difference in bacterial species between patients with and without 
prior antibiotics. Those patients with prior antibiotics (all had penicillin derivates) 
had, however, a lower number of different bacterial species in the bacterial culture 
of pus samples, which could mean that antibiotics destroyed a some bacteria. [85]. 
On the other hand, in some studies, differences especially in aerobes have been 
noticed after prior antimicrobial treatment [84]. 
It is still unclear which bacteria are real pathogens causing PTA, but the most 
frequently isolated aerobes from PTA patients´ pus samples are GAS, FN, group 
C and G Streptococcus, Staphylococcus aureus, and Haemophilus influenzae. 
Predominant anaerobic bacteria, on the other hand, are Fusobacterium spp., 
Prevotella spp., Porphyromonas spp., and Peptostreptococcus spp. [28, 55, 86, 
87] (Table 1). All these bacteria are regarded as real pathogens causing PTA. Growth 
of GAS, FN and SAG in bacterial culture is usually frequent and prominent, so 
they are regarded as major pathogens causing PTA. [3, 88]. 
According to current review, when examining from a microbiological perspective, 
there seem to be pathogenically two different subtypes of PTA. Type 1 contains a 
pure culture of a single organism, most often GAS. In type 2 extensive polybacterial 
growth can been observed, which often contains a variety of anaerobes. Clinically, 
type 2 PTA patients often have more severe disease. [3]. Recently, however, more 
specific subtypes of PTA have been presented. Patients with FN and GAS are 
younger, and high neutrophil and CRP levels are associated with FN as a pathogen 
[40, 87].  
29
Aetiology of peritonsillar abscess - role of minor salivary glands
Ta
bl
e 
1.
 N
um
be
r 
of
 p
ot
en
tia
l p
at
ho
ge
ns
 f
ro
m
 p
us
 s
pe
ci
m
en
s 
in
 s
tu
di
es
 o
f 
pe
rit
on
si
lla
r 
ab
sc
es
s 
m
ic
ro
bi
ol
og
y 
pu
bl
is
he
d 
20
0
0
-2
01
9.
St
ud
y
D
ia
gn
os
is
(n
)
G
A
S 
(n
um
be
r 
of
 
is
ol
at
es
)
G
CS
/G
G
S
Fu
so
ba
ct
er
iu
m
 s
pp
. 
(F
N
)
Vi
rid
an
s 
st
re
pt
oc
oc
ci
 
(S
A
G
)
St
ap
hy
lo
co
cc
us
 
au
re
us
H
ae
m
op
hi
lu
s 
sp
p.
M
at
su
da
 e
t 
al
. [
89
]
20
02
PT
A
72
4
48
29
8
Sa
ka
e 
et
 a
l. 
[8
5]
20
0
6
PT
A
30
7
2
11
3
1
G
av
rie
l [
58
, 8
6]
20
0
8,
 
20
0
9
PT
A
46
9
58
5
3 
4
2
Su
nn
er
gr
en
 [
42
]
20
0
8
PT
A
89
20
5
5(
2)
2
R
us
an
 [
1]
20
0
8
PT
A
62
3
10
5
20
(1
54
)
Se
ga
l [
90
]
20
0
9
PT
A
12
6
29
6
2
2
1
K
lu
g 
[4
0
] 
20
0
9
PT
A
84
7
14
1
39
19
1 
(1
91
)
15
9
H
id
ak
a 
[9
1]
20
11
PT
A
11
7
9
3
20
 (
20
)
K
lu
g 
[4
7]
20
11
PT
A
11
6
7
3
25
 (
19
)
38
 
2
H
si
ao
 [
92
]
20
12
PT
A
56
9
15
 (
2)
22
2
Ta
ke
na
ka
 [
93
]
20
12
PT
A
71
10
13
5
2
2
A
lb
er
tz
&
N
az
ar
 [
94
]
20
12
PT
A
11
2
16
12
M
az
ur
 [
35
]
20
15
PT
A
11
1
13
1
(1
)
19
 (
4)
1
Pl
um
 [
95
]
20
15
PT
A
69
19
1
9
Va
ik
jä
rv
 [
96
]
20
16
PT
A
22
6
4 
(1
)
4 
(2
)
Le
pe
lle
tie
r 
[7
5]
20
16
PT
A
41
2
67
11
10
2
20
20
Ts
ai
 [
97
]
20
18
PT
A
41
5
17
48
 (
24
)
A
li 
[9
8]
20
19
PT
A
99
0
51
5
20
3 
(1
76
)
14
0
 (
14
0
)
20
PT
A
, p
er
ito
ns
ill
ar
 a
bs
ce
ss
; F
N
, F
us
ob
ac
te
riu
m
 n
ec
ro
ph
or
um
; G
A
S,
 g
ro
up
 A
 S
tr
ep
to
co
cc
us
; S
A
G
, S
tr
ep
to
co
cc
us
 a
ng
in
os
us
 g
ro
up
30
Enni Sanmark & Née Kaltiainen
Ta
bl
e 
2.
 N
um
be
r 
of
 p
ot
en
tia
l p
at
ho
ge
ns
 f
ro
m
 t
hr
oa
t 
sw
ab
s 
in
 s
tu
di
es
 o
f 
AT
 m
ic
ro
bi
ol
og
y 
pu
bl
is
he
d 
20
0
0
–2
01
9.
St
ud
y
D
ia
gn
os
is
(n
)
G
A
S 
(n
um
be
r 
of
 
is
ol
at
es
)
G
CS
/G
G
S
Fu
so
ba
ct
er
iu
m
 
sp
p.
 (
FN
)
Vi
rid
an
s 
st
re
pt
oc
oc
ci
 
(S
A
G
)
St
ap
hy
lo
co
cc
us
 
au
re
us
H
ae
m
op
hi
lu
s 
sp
p.
A
liy
u 
[9
9]
20
0
4
AT
10
0
(1
0
)
Lo
ga
na
th
an
 [
10
0
]
20
0
6
AT
23
3
25
16
99
22
R
us
an
 [
1]
 
20
0
8
AT
10
9
25
2
Lu
dl
am
 [
10
1]
20
0
9
AT
(1
4)
H
ed
in
 [
10
2]
20
14
AT
22
0
66
15
(3
3)
Ea
to
n 
[1
03
]
20
14
AT
50
2
59
17
(2
8)
K
ja
er
ul
ff
 [
74
]
20
15
AT
10
0
26
10
(1
6)
Je
ns
en
 [
10
4]
20
15
AT
17
9
7
55
(4
3)
Ce
nt
or
 [
10
5]
20
15
AT
31
2
22
28
(4
3)
Fu
ru
nc
uo
gl
u 
[1
0
6]
20
16
AT
89
9
56
AT
, a
cu
te
 to
ns
ill
iti
s;
 F
N
, F
us
ob
ac
te
riu
m
 n
ec
ro
ph
or
um
; G
A
S,
 g
ro
up
 A
 S
tr
ep
to
co
cc
us
; S
A
G
, S
tr
ep
to
co
cc
us
 
an
gi
no
su
s 
gr
ou
p
31
Aetiology of peritonsillar abscess - role of minor salivary glands
1.10.1 Group A Streptococcus (GAS)
GAS, also known as Streptococcus pyogenes, is a betahaemolytic, Gram-positive 
coccus and regarded as the most prevalent bacteria causing AT and PTA [1, 48-50, 
84, 85, 107, 108] (Table 1 and Table 2). It is found in 10–75% of PTA cases [28, 
84]. GAS causes PTA, as isolated bacteria, more often than other pathogens and 
is the most common pathogen causing PTA between ages 14 and 25 [3, 109, 110]. 
In AT, GAS is prevalent in younger patients, mostly in the 5- to 15-year-old age 
range [20]. GAS is also met in asymptomatic carriers, and the number of culture-
positive individuals has been reported as between 0.4 and 11.2%, depending on 
age [111]. In school-aged patients with the anamnesis of recurrent tonsillitis and 
tonsillar hypertrophy, the number of culture-positive individuals is reported to be 
even higher, at 18.2% [112]. Smoking has no effect on the prevalence of GAS in 
PTA [46]. GAS’s sensitivity to penicillin is 100% and in Finland 2–3% are resistant 
to macrolides [50, 113].
1.10.2 Fusobacterium necrophorum (FN) 
FN is a species of rod-shaped Gram-negative anaerobic bacteria and especially 
associated with Lemierre’s disease [28, 107]. FN is considered a pathogenic bacteria 
in AT and PTA (Table 1 and Table 2). Several findings support this view of FN 
as a significant pathogen in tonsillar infections. Klug et al. showed that FN was 
isolated more frequently from the tonsil core samples of PTA patients than controls 
[47]. In another Danish study Klug et al. showed that the majority of FN grew in 
pure cultures which also strengthened the theory of FN being a real pathogen in 
tonsillar infections [40]. In some studies, FN has not been observed in the normal 
microbiota of human tonsils, but in other studies FN has been detected also in the 
throat swabs of asymptomatic patients [61, 99, 114]. Recently several studies have 
reported FN also as the major pathogen in tonsillar infections and even the most 
prevalent pathogen in PTA, especially among patients aged 15–35 years [40, 46, 
88, 91, 104, 115]. There is no difference in the prevalence of FN in PTA patients 
between smokers and nonsmokers [46]. FN is shown to predispose patients to a 
higher probability of renewal and it has even been speculated whether the detection 
of FN should be an indication of TE [40, 61]. 
1.10.3  Streptococcus Anginosus group (SAG)
SAG, previously called Streptococcus Milleri group, is a group of commensal, 
aerobic, Gram-positive cocci and consists of three species: Streptococcus 
intermedius, Streptococcus anginosus and Streptococcus constellatus [3, 107]. 
SAG is associated with head and neck infections and abscess formation [34]. Hidaka 
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et al. have shown an association between smoking and growth of SAG in bacterial 
culture [91]. SAG is also commonly observed with anaerobes in abscess pus samples 
[34, 91]. In older patients, especially smokers, SAG is observed more frequently 
than in younger, non-smoking patients. In older PTA patients, the signs of PTA 
are milder but the duration of symptoms as well as recovery time are longer, and 
comorbidities are more common. [35, 76, 87, 91].
1.10.4 Other bacteria
Streptococci groups C and G are also noted as throat pathogens in addition to GAS, 
FN and SAG. Streptococci belonging to groups C and G are repeatedly presented as 
some of the most numerous bacteria in bacterial cultures of AT and PTA patients 
(Table 1 and Table 2). In a Norwegian study, it was also shown that patients with 
C or G group Streptococci had the same clinical picture of AT as the patients with 
GAS. This strengthens the view that Streptococci groups C and G are independent 
pathogens in throat infections [116]. 
Staphylococcus aureus, Nocardia asteroides, Haemophilus influenzae, 
Arcanobacterium haemolyticum and Streptococcus pneumoniae have also 
been found monobacterial in bacterial cultures of PTA patients (Table 1 and 
Table 2). Which ones of these are true pathogens and which provide only a 
beneficial environment for pathogenic bacteria is not known. However, at least 
Staphylococcus aureus is likely the real pathogen, based on findings from abscess 
pus samples [3]. Besides pathogenic bacteria, tonsils are also highly colonised by 
normal microbiota. In bacterial cultures, as many as 67% of PTA patients’ pus 
samples are reported to carry no pathogen growth. [58].
1.11 Periodontitis
Periodontitis is a common infection-induced inflammatory disease of the gingiva 
and the connective tissue surrounding the tooth. Left untreated, it leads to alveolar 
bone destruction. PTA patients have considerably more periodontal diseases than 
patients with RT, and certain bacterial species, such as Fusobacterium spp. and 
SAG, have been identified in both of these disease [3, 12, 117]. Both PTA and 
periodontal diseases have been speculated to have a multifactorial nature and 
instead of a certain pathogen, there may be a synergy of certain bacteria or other 
factors influencing these diseases, although the causality between these two diseases 
is unclear [72, 118].
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1.12 Microbiology of other infections in the oral cavity
The human oral cavity, the mouth, contains more than 600 different bacteria 
species [28, 119, 120]. The number of anaerobic bacteria are manifold compared 
to aerobic bacteria in oral microbiota [28]. During the acute stage of pharynx 
inflammation in children, the number of certain bacteria (Staphylococcus aureus, 
Haemophilus influenzae, Moraxella catarrhalis, Peptostreptococcus spp., 
Fusobacterium nucleatum, Prevotella spp., and Porphyromonas spp.) in saliva 
samples has been shown to rise from 10- to 1000-fold [121]. As PTA, oral infections 
are also typically polymicrobial [72, 118, 122].
1.12.1 Porphyromonas gingivalis (POGI)
Porphyromonas gingivalis (POGI), a rod-shaped, Gram-negative anaerobe, 
is a keystone pathogen in periodontal diseases, especially in severe forms of 
periodontitis. It is a prominent component of oral microbiota and also colonises 
successfully the oral epithelium. The virulence of POGI is based on its ability 
to manipulate and decrease the host response to pathogens rather than induce 
inflammation. [72, 107, 123]. The role of POGI in aerodigestive cancers is also 
speculated about [123]. 
1.12.2 Fucobacterium nucleatum
Fusobacterium nucleatum, a rod-shaped, Gram-negative anaerobe, is an oral 
commensal bacterium and periodontal pathogen. It is also associated with other 
infections such AT, PT and PTA. [107, 124]. Smoking increases the amount of 
Fusobacterium nucleatum in the mouth, especially in patients with periodontal 
disease [124-126]. Brook et al. have also noticed a significant increase of 
Fusobacterium nucleatum-specific antibodies after pharyngitis [121].  
1.12.3 Streptococcus mutans
Streptococcus mutans (S. mutans), a Gram-positive coccus, is a major pathogen 
in the formation of dental caries and is frequently isolated in caries lesions. The 
formation of caries is, however, a polybacterial process involving many pathogenic 
and non-pathogenic bacteria. [107, 127-129]. 
1.12.4 Streptococcus salivarius
Streptococcus salivarius is commonly isolated from the oral cavity and is reported 
to cause meningitis, endocarditis and bacteraemia [127] . It may show an inhibitory 
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effect on in vitro growth of GAS [130, 131]. Probiotic effects of Streptococcus 
salivarius in pharyngeal streptococcal and viral infections have been studied, but 
no difference between the control group and the treated group has been noted [132]. 
Other studies about probiotics in AT or PTA prevention have not been published. 
Probiotics such as Lactobacillus rhamnosus GG (LGG) and Bifidobacterium 
animalis subsp. lactis BB-12 (BB-12) have been observed to decrease both the 
plaque index (criteria for evaluation of oral hygiene by measuring dental plaque) 
and gingival index (criteria for evaluation of periodontal disease based on severity 
and localization of lesion) without affecting microbiota [133]. 
1.12.5 Effects of smoking on oral microbiota
Effects of smoking on oral microbiota are controversial. In some studies smokers 
have had alterations in oral bacterial composition compared to nonsmokers [134, 
135]. However, opposite findings have also been reported [136]. The resting whole-
mouth salivary flow rate is known to have an important role in oral hygiene. An 
Iranian study group showed that salivary flow rate is significantly lower in smokers 
and this could be one mechanism explaining the higher rate of oral diseases in 
smokers. [137]. Klug et al. compared the bacteria of pus aspirates of PTA patients 
between smokers and nonsmokers, but observed no differences between groups 
[46]. No studies about the role of oral microbiota in PTA formation exist. 
1.13 Treatment of PTA
No international clinical practice guidelines are available for the treatment of 
PTA [55, 138]. Needle aspiration, ID, and abscess tonsillectomy are all efficient 
as first line treatments [139]. Antimicrobial therapy is recommended to all patients. 
Antimicrobial therapy is, however, ineffective without adequate surgical drainage. 
[28, 36]. Outpatient drainage is most often sufficient. Extraperitonsillar spread, 
observed with computed tomography, and prior recurrence of AT are indications 
for TE. [31].  
1.13.1 Prior antibiotic treatment
Before diagnosis, 21–63% of PTA patients have been treated with antibiotics [21, 33-
35, 40, 45, 48, 55, 56, 85]. Prior antibiotic treatment may have an influence on the 
possibility of obtaining a positive culture in PTA. It can also impact which bacteria 
grow in the culture or the number of growing bacteria. A trend towards more 
frequent isolation of anaerobes in specimens in PTA patients taking prior antibiotics 
has been observed. [34, 40, 50]. It is also shown that if systemic antibiotics 
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are administered to healthy individuals, there is no measurable concentration 
of antibiotics in the tonsillar surface, but in patients with GAS tonsillitis, the 
antibiotic concentration on the surface of tonsillar tissue is measurable and doses 
are therapeutic [140].
There is no consensus whether prior antimicrobial treatment prevents the 
development of PTA. In some studies, the number of PTAs decreased after prior 
antimicrobial treatment [13, 63]. On the other hand, other studies have not 
demonstrated differences in the likelihood of having PTA between patients with 
and without prior antibiotics. [27, 45, 62]. In a subgroup analysis of one study 
(comparing ´pharyngitis´ patients to ´tonsillitis´ patients), it was speculated that 
prior antimicrobial treatment could be beneficial only to patients with tonsillitis, but 
not to patients with acute beginning of symptoms and unilateral throat pain [62]. 
1.13.2 Antimicrobial treatment of PTA
There are many different national guidelines about the treatment of PTA [21, 
33, 34, 40, 45, 48, 55, 56, 85]. In Finland, 30% of PTA patients were initially 
treated with oral antibiotics, whereas the corresponding number in Sweden is 91%, 
in Norway 53%, and in Denmark 18% [138]. In Scandinavia, Great Britain, and 
Israel, the most commonly used antimicrobial agent is penicillin, with or without 
metronidazole. However, in Spain and New Zealand, amoxicillin/clavulanic acid 
is the primary antimicrobial agent of choice [21, 33, 45, 49, 138]. Clindamycin has 
also been used [51]. Wikstén et al. have shown that penicillin alone is as effective 
as the combination of penicillin and metronidazole. Metronidazole causes more 
diarrhoea and nausea and does not prevent renewal, so it is not recommended in 
adult outpatient PTA cases. [55]. 
1.13.3 Antimicrobial resistance
Amoxicillin/clavulanic acid, penicillin, and macrolides are the most commonly 
prescribed antimicrobial agents in PTA. Some causative bacteria of PTA carry 
a resistance to penicillin in the laboratory, but these patients are nonetheless 
cured with penicillin. [141]. GAS still has a 100% sensitivity to penicillin; FN is 
also susceptible to penicillin. Resistance of GAS to macrolides varies remarkably 
geographically. In Northern Ireland it has been reported to be even 26%, when 
in Finland it has been 2–3% in 2017. [40, 50, 113]. So penicillin should be used 
as a first line antimicrobial treatment because, in addition to its clinical efficacy, 
it has a narrow spectrum of activity and no resistance [50]. 
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1.13.4 Steroids
Steroids might enhance recovery after PTA but there are only a few studies about 
the subject. Chau et al. observed a small relief of pain during the first 24 hours after 
corticosteroid administration. Differences, however, disappeared in 48 hours. [139, 
142, 143]. In a large study Johnston et al. reported that steroids were prescribed to 
9% of PTA patients, but they did not examine the effectiveness [49]. In AT, a single 
low corticosteroid dose provides pain relief without any adverse effects [142, 144]. 
1.13.5 Outpatient treatment
In Finland, 50% of adult PTA patients are treated as inpatients and 50% as 
outpatients, whereas in other Scandinavian countries the number of outpatients 
is higher.
A needle aspiration and ID are shown to be equally effective methods in 
managing PTA. In UK 60% of physician preferred needle aspiration primarily and 
25% favoured ID [2, 139]. Needle aspiration has been criticised for removing the 
pus from only one area of the abscess. After needle aspiration as well as after ID, 
approximately 10–20% of patients get a re-collection of pus. [2, 145, 146]. ID is a 
bit more definitive but also more painful [2, 139]. Aspiration is also recommended 
to be undertaken prior to ID so that a physician can localise the abscess [49]. In 
a recent study it has been shown that both hospitalization time and the need for 
reopening the abscess are decreased in patients with primary ID.  
In Scandinavia, 80% of physicians routinely reopen the abscess cavity daily or 
every other day after ID [138]. In contrast, in New Zealand reopening is performed 
in 24% of cases after clinical examination and estimation of the need for reopening 
[49]. Reopening of the abscess cavity, use of broad-spectrum microbial agents 
or being an outpatient or inpatient has no effect on the probability of TE in the 
future. 25% of PTA patients undergo TE during the next 5 years. Young age and 
earlier tonsillar infections increase the risk of later TE. [56].
1.13.6 Tonsillectomy (TE)
In children aged 0 to 14 years, the primary treatment of PTA is nearly always 
abscess TE. This is due to the fact that procedures under local anaesthesia are not 
possible because of poor cooperation. In adults, abscess TE is quite rare in most 
of countries and in-office procedures are preferred. 
Abscess TE is shown to be a safe procedure. It requires only one recovery period 
compared to TE after recovery time which requires two recovery periods. Therefore, 
abscess TE (TE performed in an acute phase of PTA) reduces the overall need of 
recovery time and sick leave [2, 139]. 
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TE includes a risk of severe, potentially fatal complications, such as postoperative 
haemorrhage and dehydration. Patients with comorbidities, prior PTA, and several 
antibiotic prescriptions during the past few years are at a higher risk of developing 
complications. Thus, management of TE should be preceded by solid indications 
[2, 139, 147, 148]. When targeted to the right patients, TE appears to save costs 
and has a curative effect on a patient's quality of life. [147]. 
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2 AIMS OF THE STUDY
The aim of this study was to clarify the aetiology of PTA and the role of minor 
salivary glands in the controversial aetiology of PTA.
The specific aims were:
1. Identify bacteria and clinical factors which might potentially promote the 
renewal of PTA. (Study I)
2. Histologically analyse and compare peritonsillar tissue of AT, CT and PTA 
patients and verify the presence of minor salivary glands and possible signs 
of infection. (Study II)
3. Find out whether the serum amylase levels are elevated in PTA patients, which 
could prove the role of minor salivary glands in PTA. (Study III)
4. Find out whether the serum amylase levels could be used in differential 
diagnostics of PTA. (Study III)
5. Find out whether symptoms, clinical findings and serum CRP levels in AT and 
PTA patients are linked to a specific bacterial aetiology. (Study III)
6. Explore whether AT, PT, and PTA are associated with changes in oral microbiota 
(Study IV)   
7. Explore whether smoking, alcohol consumption and oral hygiene have an effect 
on saliva bacteria of PTA patients. (Study IV)
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3 MATERIALS AND METHODS 
All four studies in the current thesis included patients. All patients had visited 
the Department of ORL - Head and Neck Surgery, Helsinki University Hospital, 
Finland. 
3.1 Ethical consideration (studies I-IV)
The Ethics Committee of Helsinki and Uusimaa Hospital District approved 
all four studies (I: 224/13/03/02/2009, II: 51/13/03/02/2016, III and IV: 
HUS/1760/2016). All patients and healthy volunteers gave their informed written 
consent [149]. Patient recruitment and data processing was in accordance with 
Helsinki Declaration and Good Clinical Practice [150].
Table 3. The study characteristics of Studies I-IV
Study I Study II Study III Study IV
Prospective study X X X X
Time 2010-2011 2012, 2015 2012, 2015, 2017 2017-2018
Number of patients 
(n)
180 278 200 200
Bacteria samples X b X a X a
Blood samples X x X x
Saliva samples X c 
Histology samples X
Prospective clinical 
status
X X
Questionnaire X X X X
Patient charts 
evaluated
X X X X y
Earlier publications [55, 151] [149] [149] z  
a  bacterial culture
b  microarray
c   Flow cytometry
x  Serum C-Reactive protein (CRP) , Serum amylase (S-Amyl)
y  only patient group
z   only reference group data
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3.2 Study I
A total of 180 consecutive patients suffering from PTA were prospectively recruited 
in the emergency department of ORL at HUH between February 2010 and April 
2011. 18 of 180 patients had a renewal of PTA (renewal group). Patients without 
renewal formed the recovery group (n=162). There is one publication earlier 
from the same material. In that earlier study the aim was to investigate whether 
combining metronidazole and penicillin improves recovery from PTA and whether 
metronidazole prevents PTA recurrences. [55]. 
Inclusion criteria of the Study I were diagnosed PTA and age over 18. Exclusion 
criteria were allergy to penicillin or metronidazole, use of metronidazole during 
the previous month, pregnancy, breastfeeding, renal or liver insufficiency, alcohol 
abuse, participation in another clinical trial at the time, patient’s condition requiring 
in-patient care, TE scheduled within the next 30 days, or performing military 
service. All patients had given their informed written consent when participating 
in the study. All patients answered a questionnaire concerning smoking habits, 
duration of symptoms before admission, and prior antibiotic treatment. All patients’ 
medical records were analysed and all symptoms of renewal (soreness of throat, 
swallowing problems, mouth opening difficulties, fever, general condition) and 
hospital visits during the prior two months were reviewed. 
All patients were treated with ID. Before ID the peritonsillar tissue was 
anaesthetised and pus was aspirated with a 5 ml syringe and a long 25-gauge 
needle. The bacterial samples of aspirated pus were collected and analysed in a 
laboratory by using a microarray. The microarray method is described accurately 
in two earlier publications [55, 151]. Patients were randomised to get either V 
penicillin 1 million IU x3x10 and metronidazole 400mg x3x7 or V penicillin 1 
million IU x3x10 and placebo. Routine laboratory tests, such as total blood count, 
CRP or radiological imaging, were not completed. 
Statistical calculations were performed by NCSS (Kaysville, Utah, USA) 2009 
statistical analysis software using the Chi-Square, Fisher´s exact and Mann-
Whitney U-tests. P values <0.05 were considered significant.
3.3 Study II
In this prospective study, tonsil samples of 278 patients who had undergone TE at 
the ORL clinic of HUH in 2012 and 2015 were collected and evaluated. In all these 
278 patients tonsillectomies were indicated because of the diagnosis of recurrent 
AT, CT, or PTA, and the tonsils were collected in the first place for a human 
papilloma virus study. The aim of the original study was to analyse the prevalence 
of high-risk HPV and the genetic alterations in non-malignant tonsils, such as 
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tonsillitis [149]. 124 tonsil samples were selected for the current study (Study II) 
from the original 278 patients. Selection was made so that all PTA patients fulfilling 
the inclusion criteria were included. For the two control groups (AT and CT), we 
selected all patients with recurrent AT and CT in the same age range as PTA patients 
(18.47–69.48). Hence, we got three similar groups with the same size and age 
range. Patients under 18, previous tonsillotomy, and insufficient amount of tonsil 
tissue were excluded (Figure 5). We examined all patients’ medical records from 
the hospital’s data management system. All patients filled in a questionnaire about 
their general overall health, medications, and smoking habits. TE was typically 
performed approximately six months (mean 6.25 months, median 6 months, range 
1–13 months) after the diagnosis and decision to have TE. During TE, both tonsils 
were resected but only one tonsil was collected as a specimen for the study. Right 
after TE, the tonsils were fixed in formalin, cut in 2–4 sections depending on tonsil´s 
size and embedded in paraffin. 4µm slides were cut from paraffin embedded tissue 
blocks and stained with haematoxylin and eosin, for histological examination. 
Histological examination was performed by two independent physicians. A total 
of 114 tonsils were available for analysis after the former process. We analysed 
and prepared 2 to 4 slides per patient. All slides were examined for the presence 
of minor salivary glands and the location of the minor salivary glands. We also 
analysed and reported inflammation, degenerative and fibrotic changes of minor 
salivary glands, as well as histological changes in the salivary ductus. Inflammation 
was histologically defined as leukocyte infiltration into minor salivary glands and 
divided into periductal and acinar inflammation, depending on the specific location 
of leukocytes. The experienced pathologist analysed the number of leukocytes 
varying from no leucocytes to plenty of leukocytes. Statistical calculations were 
performed by NCSS 8 (Hintze, J. PASS 11. NCSS, LLC. Kaysville, Utah; 2011.  www. 
ncss.com. Accessed September 21, 2012)) 2012 statistical analysis software using 
the Chi-Square test. P values <0.05 were considered significant.
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Tonsillar samples not 
available (n=10)
Included AT, CT and PTA 
patients (n=124)
N=278
Excluded patients (n=154)
• age under 18
• tonsillotomy
• multiple ORL diagnosis
• insufficient amount of 
tonsillar tissue
AT (n=50)
CT (n=25)
PTA (n=39)
Figure 5.  Flow chart study II.
AT, acute tonsillitis; CT, chronic tonsillitis; PTA, peritonsillar abscess
3.4 Study III 
Thematerial consisted of two groups of prospectively collected patients: the acute 
group (n=112) and the reference group (n=98). In the acute group, the patients were 
suffering from throat pain and were referred to the ORL emergency department 
at HUH between February and October in 2017. The reference group consisted 
of patients who were scheduled for TE due to AT (n=55) or PTA (n=43) at the 
ORL clinic of HUH during 2012 and 2015. Patients in the reference group were 
originally recruited for another study (human papillomavirus study) [149]. 
Exclusion criteria in the acute group were age under 15 and a known pancreas 
disease. In the reference group, exclusion criteria were age under 18 and pancreas 
disease. Patients in both groups were divided into two subgroups based on 
clinical diagnosis: AT and PTA (Figure 6). Serum CRP and amylase levels were 
analysed in all patients. In the reference group the blood samples were collected 
approximately 7 months (mean [±SD]; 7.18 [5.6] months) after the acute infection. 
All patients filled out a questionnaire about their smoking habits and overall health. 
Patients in the acute group also answered questions about their current disease, 
prior antibiotics, smoking habits, alcohol consumption, and earlier tonsillar or 
peritonsillar infections. The treating physician filled out a questionnaire concerning 
the acute group patients’ oral hygiene (good/poor) and tonsillar findings (tonsillar 
erythema/tonsillar exudates/no findings/tonsillar erythema and exudates). In 
addition, in the acute group, PTA patients were treated with ID. Pus aspirate 
samples of the acute group PTA patients and throat swabs collected from the acute 
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group AT patients were sent to the laboratory for bacterial culture. Local laboratory 
Helsinki University Hospital Laboratory Services (HUSLAB) grew pus samples 
under both aerobic and anaerobic conditions and throat swab cultures from AT 
patients under only aerobic conditions. Both cultures were grown according to 
the laboratory´s standard methods for diagnostic samples. Correlations between 
smoking, alcohol consumption, signs and symptoms of infection, laboratory tests 
and bacterial samples were analysed. For statistical analysis, bacteria findings 
were first divided into five groups: 1) Streptococcus betahaemolytica (GAS, 
group B, C or G Streptococci) 2) SAG, 3) FN 4) FN + SAG and 5) other bacteria 
(Included: Haemophilus influenzae, mixed oral flora, Fusobacterium nucleatum, 
Staphylococcus aureus, Prevotella spp., Neisseria meningitides, other aerobes, 
other anaerobes). FN and FN+ SAG groups were further combined for statistical 
analysis because of the small number of patients in the groups. The acute and 
reference groups were first analysed separately and then compared. Calculations 
were performed by NCSS  8 statistical software (Hintze, J. PASS 11. NCSS, LLC. 
Kaysville, Utah; 2011.  www. ncss.com. Accessed September 21, 2012). Numerical 
variables were analysed with the Mann-Whitney U-test and Kruskal-Wallis one-
way ANOVA. The chi-square test was applied to compare nominal variables. 
Spearman rank correlation was applied to two numerical variables with non-normal 
distribution. Logarithmic transformation was applied and Pearson correlation with 
confidence intervals was calculated to compare correlation coefficients between 
groups. P values <0.05 were considered to be statistically significant. 
Acute group 
(n=112)
Reference group 
(n=98)
N=210
PTA (n=58)
AT (n=54)
AT (n=55)
PTA (n=43)
Figure 6. Flow chart of study III.
AT, acute tonsillitis; PTA, peritonsillar abscess
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3.5 Study IV
The material consisted of two groups of prospectively collected patients: the patient 
group (n=148) and heathy volunteers (n=52). In the patient group, patients having 
throat pain and fulfilling the inclusion criteria were recruited and evaluated at the 
emergency department of ORL of HUH between February and October in 2017. 
Healthy volunteers were recruited between March and April in 2018 from students 
and hospital staff. Exclusion criteria of patient group were age under 15 and a known 
pancreas disease. In healthy volunteers, exclusion criteria were acute throat pain, 
acute or chronic tonsillar infection, recent (during previous two months) antibiotic 
treatment, and age under 15. Participants in the patient group were divided into 
three groups based on clinical diagnosis: AT, PT and PTA.  
The patients received paraffin tablets to stimulate saliva secretion and the 
saliva was collected in 2 minutes. The analysis of salivary saples were performed 
by GutGuide (https://gutguide.com). The amount of 2.5 ml saliva was used 
for bacterial analysis. Concentrations of bacteria were analysed according to a 
previously published method with minor modifications [152]. Briefly, to isolate 
bacteria, saliva was aliquoted in 1.5 ml Eppendorf tubes and centrifuged at 
13,000 rpm for 6 minutes at room temperature. After that, the supernatant was 
discarded, and pellets were suspended in 200 µl of phosphate-buffered saline 
(PBS). Thereafter, we combined and centrifuged the suspensions. Supernatant was 
removed and the pellet was suspended in 1000 µl of 4% paraformaldehyde in PBS 
(w/v) to fix the bacteria. Glass beads were added to the bacterial suspensions and 
samples were combined and incubated on a shaker at 4°C overnight. To prepare 
bacterial stocks, samples were centrifuged at 13,000 rpm for 10 min at RT. After 
that, supernatant was removed, and pellets were washed twice with PBS. At the 
end, the bacterial pellet was suspended in 200 µl PBS and an equal volume of 94% 
ethanol. The samples were kept at -20°C until analysis.
Flow cytometry (FCM; BD FACSCalibur) was used to analyse the total bacteria 
concentration. To analyse the total amount of bacteria, 4 µl of bacterial stock was 
diluted in 4 ml of PBS and samples were vortexed and sonicated. After that 300 
µl of bacterial suspension was mixed with 3 µl of Sytox Orange (Molecular Probes, 
Eugene, Oregon) DNA stain (Ex/Em 547/570 nm) for FCM analysis to separate 
bacteria from nonbacterial material.
To analyse the bacterial species-specific FCM, 15 µl of bacterial stock sample 
was hybridised at least 12 hours with 16S rRNA-targeted CY5 indocarbocyanine 
(Ex/Em 646/662 nm Molecular Probes) -labelled oligonucleotide probes against 
1. Porphyromonas gingivalis [153] 2. Fusobacterium nucleatum (FN) [154] 3. 
Streptococcus mutans (S. Mutans) [154] 4. Narrow Streptococcus probe (NSP; 
Streptococcus anginosus (SAG), Streptococcus oralis and Streptococcus mitis) 
[155] and 5. Broad Streptococcus probe (BSP) [156] (Figure 7). Before FCM, 4 
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µl of Sytox Orange was added to each sample. The Ribosomal Database Project 
database (http://rdp.cme.msu.edu/html) was used to analyse the sequence match 
of the probes with the target species.
Concentrations of the bacteria were analysed using TrueCount tubes (Beckton 
Dickinson, San Jose, CA) containing an exact number of fluorescent microbeads. 
300 µl of each sample was added to a TrueCount tube and FCM analysis was 
performed until 2% of the microbeads had been observed. Bacterial samples 
hybridised with Cy5-labelled probes were analysed using the FL4 detector (661/16 
nm). Then the samples were stained with Sytox Orange DNA stain by FL2 detector 
(585/42 nm). Two parallel samples from each bacterial stock sample were run. The 
mean, standard deviation and coefficient of variation of bacterial concentrations 
were measured.
From the patient group, serum CRP and amylase levels were analysed in 
HUSLAB with an accredited, standard method for analysing serum CRP and S-Amyl 
levels. The blood samples of the patient group were analysed from fresh blood while 
the blood samples of the reference group were analysed from frozen serum samples. 
All PTA patients were treated with ID. Pus aspirate samples of the PTA patients as 
well as throat cultures from the AT and PT patients were sent to the laboratory for 
bacterial culture. A local laboratory (HUSLAB) tested both aerobic and anaerobic 
bacteria from pus samples and aerobic bacteria from throat swabs from AT and 
PT patients. Both cultures were grown according to the laboratory´s standard 
methods for diagnostic samples. The patient group filled out a questionnaire about 
their smoking habits, current disease, prior antibiotics and overall health, alcohol 
consumption, and earlier tonsillar or peritonsillar infections. The treating physician 
filled out a questionnaire concerning the patient group participants’ oral health 
(good/poor) and tonsillar finding. Oral health was evaluated by inspection. Healthy 
volunteers answered questions about recent throat infections, recent antibiotics 
during the past two months, smoking, oral hygiene (self-evaluated), and alcohol 
consumption. Alcohol consumption was considered alcohol abuse if the patient 
reported being intoxicated at least five times in one month. The limit was relatively 
high compared to Finnish Current Care Guidelines [157]. 
Correlation between smoking, alcohol consumption, laboratory tests, pus 
or superficial bacterial samples, and salivary bacterial samples were analysed. 
Calculations were performed by NCSS  8 statistical software (Hintze, J. (2012). 
NCSS 8. NCSS, LLC. Kaysville, Utah, USA. www.ncss.com). Amounts of total 
salivary bacteria were divided with 106 for statistical reasons. Log transformation 
was used on a variable to make data conform more closely to the normal 
distribution. Numerical variables were analysed with a Mann-Whitney U-test and 
Kruskal-Wallis one-way ANOVA. A chi-square test was used to compare nominal 
variables. P values <0.05 were considered to be statistically significant. 
46
Enni Sanmark & Née Kaltiainen
73 
 
Figure 7. The target group of the Broad Streptococcus probe. The figure (chart B) represents the 
bacteria species observed with Broad Streptococcus probe [156]. 
 
 
 
 
Correlation between smoking, alcohol consumption, laboratory tests, pus or superficial bacterial 
samples, and salivary bacterial samples were analysed. Calculations were performed by NCSS  8 
statistical software (Hintze, J. (2012). NCSS 8. NCSS, LLC. Kaysville, Utah, USA. www.ncss.com). 
Figure 7. The target group of the Broad Streptococcus probe. The figure (chart B) represents the 
bacteria species observed with Broad Streptococcus probe [156].
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4 RESULTS
4.1 Demographics (Studies I-IV)
4.1.1 Study I
Characteristics of patients in Study I are presented in Table 4. 
Table 4. Characteristics of peritonsillar abscess (PTA) patients in renewal group and recovery group 
in Study I.
Characteristics Study I
Renewal group
(n=18)
Study I
Recovery group 
(n=162)
Age, years
Mean 34.8 34.2
Male, n(%)
Female
13 (72)
5 (28)
85 (52)
77 (48)
Smoker, n(%) 7 (39) 65 (40)
Prior antibiotics n(%) 
Yes 7 (39) 48 (30)
Duration (days) of symptoms prior PTA, n(%)
1-4 days
>4 days
9 (50)
9 (50)
47 (29)
115 (71)
PTA, peritonsillar abscess
4.1.2 Study II and Study III
Characteristics of patients in Studies II and III are presented in Table 5. In Study 
III 3.4% (2/58) of PTAs were bilateral and none of the patients had a complication 
during the first three months.
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4.1.3 Study IV
Characteristics of patients of Study IV are presented in Table 5.
Table 6. Characteristics of patients with AT (n=54), PT (n=36), PTA (n=58) and healthy volunteers (n=52) 
Characteristics AT (n=54) PT (n=36) PTA (n=58) Healthy volunteers 
(n=52)
Age 
Mean[±SD]
Median
Range
30.5 [±12.0]
28.5
15-86
36.2 [±18.3]
28.5
17-85
35.7 [±12.6]
36
16-65
37.4 [±11.0]
25.8
19-67
Gender, n (%)
Male
Female 
21 (38.9)
33 (61.1)
18 (50.0)
18 (50.0)
36 (62.1)
22 (37.9)
19 (36.5)
33 (63.5)
Smoking, n (%)
Yes
No
Ex-Smoker
22 (40.7)
20 (37.0)
12 (22.2)
6 (17.1)
21 (60.0)
8 (22.9)
24 (42.1)
21 (36.8)
12 (21.1)
0 (0)
52(100.0)
0 (0)
Alcohol abuse, 
5 or more 
times a month 
intoxicated n (%)
4 (7.4) 1 (3.4) 5 (8.6) 0 (0)
Prior antibiotics 
for more than 24 
hours, n (%)
9(16.7) 7(20.6) 10(17.2)
No prior 
antibiotics
Oral hygiene, 
n (%)
Good
Poor
No information
48 (90.6)
5 (9.4)
1
32 (94.1)
2 (5.9)
2
51 (91.1)
5 (8.9)
2
52 (100.0)
0
PTA, peritonsillar abscess; AT, acute tonsillitis; CT, chronic tonsillitis. 
4.2 Bacterial findings (Studies I and III)
Bacteria samples were taken in Studies I and III. In Study I, analysis on aspirated 
pus of PTA patients was performed by the microarray assay. In Study III, aspirated 
pus of PTA patients as well as throat swabs of AT and PT patients were analysed 
by bacterial culture. The identified bacterial species are presented in Table 7. In 
Study I, in 20 samples two different bacterial species were detected. In Study 
III, according to HUSLAB protocol, clinically significant bacterial findings were 
reported by the laboratory; other findings were reported as normal flora, mixed 
aerobes, and mixed anaerobes.
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Table 7. Bacterial findings in Study I and Study III.
Bacteria Study I
PTA (n=180)
n (Number of 
specimens with 
another species) 
Study III
PTA(n=57)
Study III
AT (n=54)
Group A streptococci 40 (4) 13 22
Group C or G streptococci 1 2
Streptococcus anginosus 12 (10) 9
Fusobacterium necrophorum 44 (5) 3
Haemophilus influenzae 14 (8) 2
Fusobacterium nucleatum 1
Staphylococcus aureus 4 (1) 2
Prevotella spp. 30 (10) 2
Neisseria spp. 2 1
Coagulase negative staphylococci 4
Streptococcus viridans group 6 (1)
Streptococcus pneumoniae 4
Aggregatibacter aphrophilus 2
Peptostreptococcus spp. 2
Streptococcus dysgalactiae  
subsp. equisimilis
2 (1)
Bacteroides fragilis group 1
Enterobacter cloacae 1
Lactobacillus delbrueckii  
subsp. bulgaricus
1
Streptococcus anginosus and 
Fusobacterium necrophorum
3
Haemophilus influenzae and
Fusobacterium nucleatum
1
Mixed aerobes 1
Mixed anaerobes 7
Mixed oral flora 12 28
No samples analysed 11 1
PTA, peritonsillar abscess; AT, acute tonsillitis
52
Enni Sanmark & Née Kaltiainen
4.2.1  Study I 
18 (10%) of PTA patients (renewal group) had a renewal episode during the follow-
up period (2 months). None of the patients in the renewal group had GAS as the 
only finding, whereas in the recovery group, this was the case in 40 patients (p 
=0.014). SAG was observed in 5/18 (28%) of the renewal group’s bacterial samples 
whereas in patients without a renewal (recovery group), SAG was found in 7/162 
(4%) of the bacterial samples (p=0.003). In addition, 75% of patients under the age 
of 25 had FN as a pathogen. There was no difference in age (p=0.722), smoking 
habits (p=0.837), or gender (p=0.110) between the groups. 72% of the renewal 
group were men, when in the recovery group the number was 52%. Patients over 
the age of 40 comprised 39% of the renewal groups and 31% of the recovery group. 
All patients with SAG were nonsmokers. None of the renewals occurred during 
the summer months (June–August). Specific characteristics of the renewal group 
are presented in Table 8. 
Table 8. Characteristics of the renewal group (n=18)
Bacteria Gender Age (years) Renewal (days)a
FN F 18 1
FN F 19 14
FN M 20 15
FN M 21 15
FN M 22 17
FN M 22 14
FN F 25 2
FN M 46 1
FN M 64 4
SAG + PO M 24 42
SAG + PO M 40 14
SAG + PO M 40 2
SAG + PO M 47 1
SAG + PO M 57 1
Other F 21 19
Other F 31 5
Other M 53 6
Other M 60 1
FN, Fusobacterium necrophorum; SAG, Streptococcus anginosus group; O, Prevotella oris; M, male; F, female
a   Renewal is presented as number of day between primary episode and renewal of peritonsillar abscess.
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In subgroup analysis, we observed that in patients over 40 years the renewal 
happens after a shorter period compared to younger patients with a PTA renewal 
(p= 0.013). All these older patients with a quick renewal were male when in younger 
group only half of the patients were male (p=0.036). In the group of older patients, 
SAG was detected as a dominant pathogen in 50% of samples (4/8), when in the 
group of younger patients only 1/10 had SAG as a major bacterium (p=0.118).
4.2.2  Study III
For the statistical analysis bacteria findings were divided into five groups: 1) 
Streptococcus betahaemolytica (GAS, group B, C or G streptococci) 2) SAG, 
3) FN, 4) FN + SAG and 5) other bacteria (Included: Haemophilus influenzae, 
mixed oral flora, Fusobacterium nucleatum, Staphylococcus aureus, Prevotella 
spp., Neisseria meningitides, other aerobe, other anerobes; see Table 9). To get 
reliable statistical analysis, FN and FN+ SAG had to be combined. Bacterial samples 
were taken only from the acute group (n=112) and the comparison was performed 
between AT and PTA patients.
Table 9. Bacterial findings in patients with AT or PTA.
Bacteria n (%) ATa
(n=54)
PTA
(n=56)
Betahaemolytic streptococci 24 (44.4) 16 (22.2)
Group A streptococci 22 (40.7) 13 (18.1)
Group B, C or G streptococci 2 (3.7) 3 (4.2)
Streptococcus anginosus group 0 (0) 11 (15.3)
Haemophilus influenzae 2 (3.7) 1 (1.4)
Neisseria meningitidis 0 (0) 1 (1.4)
Staphylococcus aureus 0 (0) 3 (4.2)
Other aerobic bacteria 0 (0) 0 (0)
Fusobacterium necrophorum 5 (6.9)
Other anaerobic bacteriab 22 (30.6)
Mixed regional microbiota 28 (51.9) 13 (18.1)
AT, acute tonsillitis; PTA, peritonsillar abscess 
a Only aerobic culture was done from patients with acute tonsillitis (AT).
b Other anaerobic bacteria isolated: anaerobic Gram-negative rods (n=14), Prevotella species (n=2),     
  Fusobacterium species other than necrophorum (n=4), anaerobic mixed flora (n=2)
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In AT or PTA group, there were no differences in S-Amyl and CRP levels between 
bacterial groups (AT: p= 0.620 and p=0.331; PTA: p=0.925 and p= 0.203).  
Among PTA patients who were on antimicrobial treatment before the diagnosis, 
SAG was significantly more frequent than other bacteria (p= 0.0374). AT patients 
with betahaemolytic Streptococci (mainly GAS) in the bacterial culture had a shorter 
duration of symptoms before contacting the hospital, compared to patients with 
other bacteria in culture (p=0.0125). In the PTA group, no association between 
bacteria and duration of symptoms was noted (p=0.628). We did not observe an 
association between certain bacteria and patients’ symptoms (unilaterality, lack 
of common cold, fever) either in the AT or PTA group (AT p=0.472, p=0.123 
and p=0.618; PTA p=0.232, p=0.891, p=0.731). Neither the history of tonsillar 
infections (AT p=0.484 and PTA p=0.816) nor tonsillar findings (AT p=0.653 and 
PTA p=0.057), had an association with bacteria findings. In AT or PTA groups oral 
hygiene had no impact on bacterial findings (p= 0.803 and p=0.420).
In a subgroup analysis, SAG was found in significantly older patients (mean age 
43.4 years) than bacteria from other bacterial groups (betahaemolytic Streptococci 
31.8 years, other bacteria 33.6 years, combined FN and FN +SAG 26.0 years, p= 
0.0219). Seven out of nine (77.8%) patients with SAG were male.
4.3 Pathologic-anatomic diagnosis (PAD) (Study II) 
Tonsil samples of 114 patients were histologically analysed in Study II. Patients 
were divided into three groups based on indication of TE: i.e. AT, CT and PTA. 
Histological findings were compared between the groups. 
4.3.1  Study II
In Study II we identified histologically minor salivary glands from 67.5% (77/114) 
of the tonsil samples. The majority of the minor salivary glands were located 
superficially near the tonsil, but they were also observed deeper, inside the muscle 
tissue in 17.5% (20/114) of tonsil samples. Between the AT, CT, and, PTA groups, 
there was no difference in the presence of minor salivary glands (p=0.372). Infection 
of minor salivary glands was observed in 94.8% (n=73) superficially located glands 
but in only 15% (n=3) of the glands that were located deeper, inside the muscle 
tissue (Figure 8).
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Muscle tissue Minor salivary gland
Figure 8. The deeper-located minor salivary gland without any signs of inflammation inside the muscle 
tissue. Photo: Sanmark/Hagström.
Periductal inflammation, i.e. intense invasion of leukocytes around the ductus 
draining from the minor salivary gland, was demonstrated in 82.1% of the PTA 
patients´ samples, 57.1% of AT patients´ samples, and 42.9% of CT patients´ 
samples (p=0.011) (Figure 9).
The amount of acinar inflammation, i.e. invasion of leukocytes between the 
clusters of gland cells, did not differ between the groups (PTA 50%, AT 60%, and 
CT 57.1%) (p=0.725). The number of previous PTAs had no effect on the presence 
of minor salivary glands (p=0.970) or periductal inflammation (p=0.211).
Only one tonsil was analysed from every patient and in 21/39 of the patients, 
the analysed tonsil was from the same side as the previous abscess. There was 
no difference in the presence of salivary glands (p=0.170) or inflammation signs 
(p=0.413) between the tonsils from the abscess side and from the non-abscess side. 
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Ductus of the minor 
salivary gland
Periductal inflammation 
(invasion of leukocytes)
Minor 
salivary 
gland
Figure 9. Periductal inflammation (blue dots) around the ductus of the minor salivary gland. Acinar 
inflammation is seen on the right side of the picture. Photo: Sanmark/Hagström.
Fibrosis was evident in 20 specimens and degeneration in 8 specimens. In 62 
(54.5%) specimens, actinomyces-like bacteria were observed. The presence 
of actinomyces-like bacteria did not differ between AT, CT, and PTA patients 
(p=0.220) (Figure 10).
The tonsillar crypt
Tonsillar tissue
Actinomyces- 
like bacteria
Figure 10. Actinomyces-like bacteria in tonsillar crypt. Photo: Sanmark/Hagström.
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Patients’ smoking habits were not associated with the presence of superficial or 
deeper salivary glands (p=0.964 and p=0.171), periductal or acinar inflammation 
of salivary glands (p=0.758, p=0.115), nor the presence of actinomyces-like bacteria 
(p=0.988).
4.4 Laboratory results (Study III and IV)
Laboratory tests, more specifically S-Amyl and CRP, were analysed from all patients 
in Studies III and IV. In Study III the blood samples were taken during acute 
infection in the acute group and in the post-infectious stage in the reference group. 
Signs and symptoms of infections were recorded and evaluated only from the 
acute group, so analyses of the association between the signs and symptoms of the 
infection, and S-Amyl and CRP levels were performed only in this group.
4.4.1 Correlation of serum amylase (S-Amyl) and CRP in the 
acute and reference group 
In the acute group, a significant negative correlation was noted between S-Amyl and 
CRP levels in both AT and PTA patients (AT r=-0.3475, PTA r= -0.353) (Figure 11). 
 
a)                                                                                 b) 
 
                                                                                             
                      
 
 
 
a)                                                                                 b) 
 
                                                                                             
                      
 
 
Figure 11. Correlation between serum amylase (Amyl) and CRP levels in patients with a) acute tonsillitis 
(r=-0.519) and b) peritonsillar abscess (r=-0.353).
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In the reference group, PTA patients had a slightly negative correlation (r= -0.160) 
and in AT patients, a positive correlation (r=0.125) but these correlations were not 
significant. There was a significant difference in correlations between the acute and 
reference groups (acute group r= 0.4248 CI [-0.2516, -0.5688], reference group 
r=0.0112, CI [-0.1868, 0.2082]) (Figure 12).a)                                                                             b) 
 
  
a)                                                                             b) 
 
   Figure 12.  Correlations between serum amylase (Amyl) and CRP in reference group (a) and in prospective 
group (b).
S-Amyl and CRP are changed to logarithm numbers so that they are distributed 
normally before calculating correlations. 
In the acute group neither alcohol consumption nor smoking habits had any effect 
on S-Amyl levels in AT or PTA patients (p=0.750, p=0.205). In the reference 
group patients, smoking habits had no influence on S-Amyl levels either (p=0.625). 
S-Amyl was significantly lower in AT (median 41 U/l, range 15–125 U/l) and PTA 
(median 44 U/l, range 15–116 U/l) patients of the acute group compared to the 
AT (median 50 U/l, range 23–105 U/l) and PTA (53 U/l, range 28–109 U/l) 
patients in the reference group. Differences were significant in both groups AT 
(p=0.017) and PTA (p=0.026). CRP level in the acute group both in AT (median 
87 mg/l, range 3-373 mg/l) and PTA (median 60mg/l, range 3-313 mg/l) patients 
was significantly higher than in the reference group’s AT (median 3mg/l, range 
3-10 mg/l) and PTA (median 3mg/l, range 3-9 mg/l) patients. Differences were 
significant in the AT group (p<0.0001) and the PTA group (p<0.0001). In the 
acute group, there were no differences in S-Amyl or CRP levels between AT and 
PTA groups (p=0.767 and p=0.501). 
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4.4.2 Association of laboratory test results with signs and 
symptoms 
AT patients without fever had a higher S-Amyl and lower CRP value than patients 
with fever (65.5 U/l vs 37.5 U/l, p=0.0121 and 15mg/l vs 104.5mg/l, p=0.00037). 
In the PTA group, there was no difference in S-Amyl or CRP levels between the 
febrile and non-febrile patients (p=0.637 and p=0.239). AT patients with shorter 
duration of symptoms had higher CRP levels than patients with longer duration 
of symptoms (94 mg/l vs. 80mg/l, p=0.063), but in S-Amyl levels there was no 
difference (p=0.650). In the PTA group, there were no differences in S-Amyl 
or CRP levels when comparing patients with a different duration of symptoms 
(p=0.655, p=0.720). AT patients with bilateral symptoms had higher CRP (110 
mg/l vs. 75.5mg/l, p= 0.031) and lower S-Amyl levels (30.5 U/l vs 46U/l, p=0.033) 
than patients with unilateral throat pain. In PTA patients, the difference was 
not significant (CRP:120.5mg/l vs 60mg/l, p= 0.522. S-Amyl: 32.5U/l vs 44U/l 
p=0.175). PTA patients with common cold had higher S-Amyl than those without 
common cold symptoms (51 U/l vs 41 U/l, p=0.0096). In CRP levels, there was no 
difference (36mg/l vs 82mg/l, p=0.0755). In AT patients, there was no difference 
in S-Amyl or CRP levels between patients with or without common cold (p=0.914 
and p=0.575). Poor oral hygiene had no effect on amylase or CRP levels (p=0.627 
and p=0.680). History of tonsillar infections (recurrent AT, CT, PTA) did not cause 
changes in S-Amyl or CRP levels in AT or PTA patients either (AT patients p=0.151 
and p=0.971. PTA patients p=0.852 and p= 0.410). 
4.4.3 Association of laboratory test results and tonsillar findings
Eight PTA patients had no signs of infection (tonsillar erythema, tonsillar exudates, 
and both) in their tonsils. These 8 PTA patients had significantly lower CRP levels 
(median 15 mg/l, range 3-40mg/l) than PTA patients with tonsillar findings (median 
S-CRP 60mg/l, range 3-313 mg/l, p=0.00063). In S-Amyl level the difference was 
not significant (p=0.19) (Figure 13).
Eight patients were significantly older (median 50.5 years) than other PTA 
(median 34 years) patients (p=0.006). Bacteria culture findings of PTA patients 
without tonsillar findings are presented in Table 9.
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Table 9. Bacterial species cultured from PTA patients without signs of infection in tonsils.
Bacteria species PTA patients without tonsillar findings 
(n=8)
Staphylococcus aureus and Gram-negative bacillus 2
Gram-negative bacillus 2
Fusobacterium nucleatum 1
Coagulase-negative Staphylococci and coliform bacillus 1
Group A Streptococci 1
Group A Streptococci and gram-negative bacillus 1
PTA, peritonsillar abscess
In AT patients, tonsillar findings (tonsillar erythema, tonsillar exudates and both) 
were not associated with S-Amyl or CRP levels (p= 0.306 and p=0.363).
4.4.4 Association of laboratory results and salivary samples
No correlation between the amount of saliva bacteria and serum CRP (p=0.429) 
or S-Amyl (p= p=0.941) was noted. Neither in subgroup analysis between different 
salivary bacteria and serum CRP and S-Amyl were correlations observed.
4.5 Salivary bacteria (Study IV)
We observed no difference in the amount of total salivary bacteria between AT, 
PT and PTA groups (p=0.273) or between patients with acute throat infection 
(patient group) and healthy volunteers (p=0.104) (Figure 14). 
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Figure 14. The median concentration (/ml) of saliva bacteria in AT, PT, and PTA patients, as well as 
in healthy volunteers
PTA, peritonsillar abscess; AT, acute tonsillitis; PT, peritonsillitis
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Distribution between bacteria species in AT, PT, and PTA patients (patient group) 
and healthy volunteers is demonstrated in Figure 15. Healthy volunteers had a 
significantly higher amount of POGI (p=0.00003) (Median amount of bacteria 
AT: 0.257x106; PT: 0.0426x106 ; PTA 0.0523x106 ; Healthy volunteers 0.3715x106).
Figure 15. The median concentration (/ml) and distribution of saliva bacteria in A) AT, B) PT, C) PTA 
patients and D) healthy volunteers
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Smokers had a significantly (p=0.00074) lower rate of Fusobacterium nucleatum 
in their saliva compared to nonsmokers and ex-smokers (median number: smokers 
0.77x105, nonsmokers 2.1X105 and ex -smokers 5.41x105). Ex-smokers had a 
significantly higher amount of Streptococcus group bacteria compared to smokers 
and nonsmokers (p=0.028) (median number smokers: 3.2 x106, nonsmokers 4.5 
x106, ex-smokers 14.6 x106). Patients’ smoking status had no effect on the amount 
of SAG (p=0.068), POGI (p=0.483), or S. mutans (p=0.164). The distribution of 
saliva bacteria is demonstrated in Figure 16. 
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Figure 16. The median concentration (/ml) distribution (%) of saliva bacteria in A) smokers, B) 
nonsmokers and C) ex-smokers
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The total amount of bacteria did not differ between patients with different 
smoking status (p=0.0866). In a subgroup analysis, ex-smokers in the AT group 
had a significantly higher total number of bacteria (p=0.0428), group of SAG, 
mitis and oralis (p=0.049) and Fusobacterium nucleatum (p=0.0013) compared 
to smokers and nonsmokers. In other saliva bacteria, there was no significant 
difference between patients’ smoking habits. In PT or PTA groups, significant 
differences were not noted either in the amount of saliva bacteria in patients with 
different smoking habits. 
Alcohol consumption did not affect the total amount of saliva bacteria (p= 
0.141), but those patients who don´t consume any alcohol had higher amounts of 
SAG, mitis and oralis group (p=0.046) and POGI (p=0.036) in their saliva. When 
analysing different diagnostic groups (AT, PT and PTA), PT patients who did not 
use alcohol had a higher amount of POGI than those PT patients who used alcohol 
(p=0.019). There were no differences in the AT or PTA group.
Patients’ oral hygiene (good/poor) had no effect on the total number of salivary 
bacteria (p=0.621). Distribution between bacteria in patients with different oral 
hygiene is presented in Figure 17. Prior use of antibiotics didn´t affect to the total 
amount of saliva bacteria (p=0.656) or specific bacteria species.
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Figure 17. The concentration ( /ml) and distribution of saliva bacteria in throat infection patients with 
A) good B) poor oral hygiene
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No correlation between saliva bacteria and serum CRP (p=0.429) or S-Amyl 
(p=0.941) was noted. There was no correlation between age and salivary bacteria 
either. Earlier tonsillar infection had no effect on salivary bacteria (p=0.941). 
Patients with Streptococcus in their throat or pus sample had no more Streptococcus 
in their saliva than patients with other pathogens in their throat or pus sample 
(p=0.291). The same results came out with SAG (p=0.811). Other bacteria groups 
stayed so small that reliable analysis could not be run.
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5 DISCUSSION
In this thesis we clarified the aetiology of PTA and showed that it is possible 
that PTAs do not always begin as a complication of AT, but as an infection of 
minor salivary glands. Our study also showed that the changes in concentration 
or distribution of saliva bacteria do not explain the higher rate of PTAs in patients 
with periodontal disease or who are smokers. We identified the minor salivary 
glands in most of the tonsil specimens collected after TE due to recurrent AT, 
CT, or PTA and showed that patients with PTA had significantly more intense 
periductal infection than patients with AT or CT. We also observed that neither 
smoking habits nor oral hygiene has any effect on the number or distribution of 
salivary bacteria in patients with tonsillar infection.
We also showed with an adequate number of patients that PTA patients are not 
a uniform group of people but there are subgroups with different bacterial findings, 
different clinical pictures, and different laboratory test results. We demonstrated 
some subgroups of PTA patients with different bacterial findings, different clinical 
pictures, and different laboratory test results: 1) SAG predisposes for renewal of 
PTA whereas GAS is not related to renewal episodes. 2) The renewal episodes were 
observed especially in two subgroups: older males with SAG and young women 
with FN. 3) Some PTA patients had no tonsillar findings in clinical examination 
whereas all AT patients had tonsillar erythema, tonsillar exudates, or both. 4) 
PTA patients presenting without tonsillar erythema and tonsillar exudates had 
significantly lower S-CRP levels than PTA patients with tonsillar findings.
5.1 Patient features 
Altogether patient features, such age and gender of PTA patients in our Studies I, 
II, III and IV, are in line with the literature. 
In Study II age distribution was similar to that shown in the literature. Compared 
with the literature, a slight difference in age distribution in Studies I, III and IV can 
be explained by the fact that the incidence of PTA is highest in teenagers, and age 
over 18 (and age over 15 in Study III reference group) was our inclusion criteria 
[3, 34, 41]. In Studies I, III (acute group), and IV the distribution of gender was 
similar to that presented in literature but in Study II, as well as in the reference 
group in Study III, females predominated over males [21, 41]. Smoking has been 
associated with increased risk of PTA and in previous studies, as many as 30% of 
PTA patients have reported daily smoking. We also observed a higher smoking 
rate compared to the general population in all our studies. In Finland 13% of all 
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adults were smoking daily in 2013 (15% of males and 12% of females) [46, 48, 158]. 
We also observed a high number of ex-smokers among PTA patients in Studies 
II, III, and IV [46, 48, 91]. The number of PTA patients treated with antibiotics 
before diagnosis has varied between studies, but our Studies I, II and III adapt 
to the literature, as well as in the duration of the symptoms before contacting the 
hospital [21, 33, 34, 40, 45, 48, 55, 56, 85]. 
In Study II, AT and CT patients´ age distribution cannot be analysed reliably 
because the groups were comprised based on age range. Equal range and median 
age are, however, reported in literature. In Studies III and IV patients are a little 
older. The most likely reason is that the highest incidence of AT is between 5 to 15 
years of age and in our studies these patients were excluded [3, 11, 20, 21, 159] .
It has earlier been shown that smoking and alcohol consumption can elevate CRP 
and S-Amyl levels [46, 160]. In Study III we did not observe such elevation in CRP 
or S-Amyl levels in smokers or in patients with alcohol consumption. Poor dental 
hygiene has also been proposed to predispose to PTA. PTA patients have been 
shown to suffer considerably more often from periodontal diseases than patients 
with RT. In Study III, only 9.1% of patients had poor dental hygiene and it was 
not dependent on diagnosis (PTA, AT).
In this thesis we examined whether patients’ features, such as age and gender, 
are associated with certain pathogens or the course of disease. 
5.2 Bacterial findings
Our major finding in Studies I and III was that SAG predicts a renewal, especially 
a rapidly proceeding renewal, of PTA and is found in older male patients. GAS 
was not observed to be related to renewal episodes. This strengthens the theory 
about different aetiological factors causing PTA.
In Study I, FN was the most prevalent pathogen in PTA patients, GAS was the 
second and Prevotella spp. was the third. In Study III, the order was different as 
GAS was the first, SAG the second, and FN the third. In a recent Danish study, FN 
was the most prevalent pathogen in PTA. In the same study, prevalence of GAS 
was the second highest and group C Streptococcus the third [40]. 
Over 20 years ago, a Finnish study group expressed similar results about the 
tendency of renewal in PTAs caused by SAG (43%) and FN. They also found 
that GAS (25%) did not cause renewals as frequently as other bacteria [57]. 
Anaerobic, and mix of aerobic and anaerobic bacteria also increase the risk on 
recurrence [57, 58, 145]. Based on these facts and our findings, bacterial culture, 
and microarray assay, microbiology may have a role in filtering PTA patients with a 
higher likelihood of renewal. For these patients, abscess TE as a first line treatment 
could be beneficial. On the other hand, for patients with GAS, aspiration or ID is 
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a favourable treatment. Bacterial culturing has not been regarded as a beneficial 
tool when planning the treatment of PTA [50]. One relevant reason for this is the 
slowness of the bacterial culture as well as the difficulty of taking samples. When 
the method has no use in everyday circumstances in hospitals and health-care 
centres, it leads to lack of protocols to choose adequate treatment based on bacterial 
findings. So physicians do not necessarily know how to benefit from the results 
of bacterial culture. Nowadays, when novel bacteria systems such as microarray 
assay have been developed and also proved to be reliable and accurate, perhaps 
the role of bacteria identification in treatment should be reconsidered. Use of 
bacterial findings in targeting the right treatment to the right patient could save 
costs and prevent renewals. 
We also showed that patient characteristics may predict the renewal. Recently, 
FN has been reported to be the major bacteria causing PTA among young adults. 
This is in line with our results also. [40, 46, 88, 91, 104, 115]. GAS also appears 
more likely in younger patients [87]. PTA in older patients differs in many ways 
from PTA in young adults. Signs of PTA are milder, and fever and trismus are 
rare. On the other hand, the duration of symptoms as well as recovery time are 
longer and comorbidities are more common. [35, 76, 87]. Also, in our Study I, the 
course of disease as well as the bacterial findings in older patients differed from 
those in younger patients, being more intense and faster renewal of the disease. 
Based on our studies, older male patients need more active treatment, outpatient 
controlling, or reopening of abscesses. The choice of antibiotics is known to have 
no influence on the probability of renewal [55]. Maybe daily reopenings or abscess 
TE should be an option for these patients.
Antibiotic treatment does not necessarily alter the ability to obtain a positive 
culture in PTA but there is a trend towards more frequent isolation of anaerobes 
in specimens in PTA patients with prior antimicrobial therapy [34, 40, 50]. On 
the other hand, from patients who have not received prior antibiotics, pathogenic 
bacteria have been isolated more frequently [35]. In Study III, 5/9 (55.6%) of PTA 
patients with prior antibiotics had SAG in bacterial culture and no AT patients 
with prior antimicrobial treatment had pathogenic bacteria in bacterial culture. 
In our studies we specified bacteria only by the species and not the different 
serotypes of the bacteria. Examples of different serotypes are the M protein (emm) 
types in GAS. M protein is an important virulence factor of GAS by intermediating 
antiphagocytic activity, decreasing the opsonisation, adhering to host tissue and 
invading the cells. GAS with the lack of M protein is readily phagocytosed, and 
the antiphagocytic potential of GAS is serotype-specific [161]. The most common 
serotypes causing severe infections are M1 and M3. M protein is decreasing the 
ability to opsonise by binding complement regulators factor H and FH-like protein 
1 [162]. A Finnish research group has shown that certain allotypes of factor H and 
FH-like protein 1 are associated with weakened binding of GAS to these complement 
70
Enni Sanmark & Née Kaltiainen
factors, and thus also weakened virulence of GAS. This finding suggests that certain 
gene variants protect from GAS infections such as tonsillitis and PTA. [163-165]. 
The same group has also shown the association between the psoriasis risk allele 
and increased rate of recurrent streptococcal tonsillitis [166]. According to these 
findings, the serotype of bacteria and the genotype of the host can also have impact 
on the course of disease such as tonsillitis and PTA. These factors should also be 
taken into account when studying the different aetiological factors of tonsillitis 
and PTA as well as when examining novel treatments of streptococcal diseases.
5.3 PAD findings
In Study II, tonsils were analysed histologically. We had two main findings: presence 
of the minor salivary glands in a majority of the patients and significant periductal 
infection in PTA patients.
The minor salivary glands were demonstrated in most (67.5%) of the tonsil 
specimens of AT, CT, and PTA patients. The majority of the minor salivary glands 
were located superficially near the tonsil capsule, but we identified minor salivary 
glands also deeper, inside the muscle tissue. While we analysed only one tonsil 
per patient, Kraitrakul et al. has previously analysed both tonsils, and detected 
the minor salivary glands in 96.4% of patients (either one of the tonsils). In a 
Kraitrakul et al. study, some patients had minor salivary glands in only one tonsil; 
the presence of minor salivary glands in one tonsil varied between 87% and 91%, 
which is in line with our findings. [5]. We are the first to report deep-located 
minor salivary glands.
In Study II, we found that PTA patients have significantly greater periductal 
infection (infiltration of leukocytes around the draining duct of the minor salivary 
gland) of the minor salivary glands compared to AT or CT groups. Undefined 
(acinar/periductal) inflammation of the minor salivary glands in PTA patients 
has been demonstrated in a few earlier studies [4, 7]. Kraitrakul et al. have also 
reported a slight inflammation in the periductal space in histologically examined 
tonsil specimens, but not in their 3 PTA patients. In PTA patients they observed 
neither any fibrotic nor degenerative changes. [5]. In our study, we were able to 
identify fibrotic and degenerative changes in tonsil specimens. Statistical analysis 
remained unreliable because of the small sample size.
We observed actinomyces-like bacteria in 55% of patients and there were no 
differences between subgroups (AT, CT, PTA). Previously, when analysed from pus, 
the prevalence of actinomyces-like bacteria in PTA patients has been reported to 
be 23% [28]. Histological analysis in PTA patients has not been reported, but in 
CT and sleep apnoea patients, actinomyces spp. have been observed in 36–41% 
of patients. These numbers are a little lower than in our data. [167, 168]. We 
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did not find any single factor exposing the actinomyces-like bacteria. In a recent 
study, a lower proportion of actinomyces-like bacteria of all bacteria in smokers 
was noted [169].
5.4 Laboratory test findings
Laboratory test (S-Amyl and S-CRP) results were analysed in Studies III and IV 
( S-Amyl normal reference 28–100 U/l, S-CRP normal reference 0.05–3 mg/l). 
As the main findings, we showed a negative correlation between S-Amyl and CRP 
and also identified the group of 8 PTA patients without signs of infection in their 
tonsils. These patients had significantly lower CRP and they were significantly 
older than other PTA patients.
5.4.1 Correlation of serum amylase (S-Amyl) and CRP levels
An inverse correlation between S-Amyl and CRP levels was found only in the 
acute group. This indicates that the activation of minor salivary glands during the 
infection is transient and is related to infection. No difference in S-Amyl levels 
between acute group patients with or without a history of recurrent AT or PTA 
episodes was noted. This observation differs from the El Saied et al. study, which 
demonstrated significantly lower pus amylase in patients with a recurrent PTA. 
They did not report S-Amyl levels in patients with recurrent PTA [8]. In the recent 
Estonian study, the research group reported increased pus amylase levels in some 
of the PTA patients (13%). The median S-Amyl level in PTA patients was 45.3 
U/l and range 20–108 U/l), which is in line with our results. [170]. The Estonian 
group did not observe the tonsillar findings of the patients or report the correlation 
between CRP and S-Amyl levels. Nor did they report the subgroup analysis of the 
12 patients with the elevated pus amylase levels. This study, however, strengthens 
our findings about different subgroups of PTA patients with potentially different 
causative agents of the PTA.
We did not observe any difference in CRP levels between AT and PTA patients. 
This is in line with Tachibana et al. findings [36]. We did not observe the difference 
in S-Amyl levels, either, between AT or PTA patients. Earlier El Saied et al. detected 
a difference in both serum and pus amylase levels between PTA patients and deep 
neck abscesses and also PTA patients and dental abscesses. [8, 9]. 
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5.4.2 Association of laboratory test results between signs and 
symptoms 
We observed that afebrile AT patients had lower CRP and higher S-Amyl levels than 
febrile patients. One could even speculate that salivary gland activation sometimes 
also occurs in AT, although this hypothesis has not been presented earlier [20, 171]. 
AT patients with unilateral symptoms had lower CRP and higher S-Amyl levels 
than patients with bilateral throat pain. This could suggest some kind of activity 
in the minor salivary glands. 
5.4.3 Association of laboratory test results and tonsillar findings
Eight PTA patients had no signs of infection in their tonsils in the clinical 
examination. In contrast, all AT patients had tonsillar erythema, tonsillar exudates 
or both. PTA patients without tonsillar findings in a clinical examination had 
significantly lower CRP levels than other PTA patients. We also noted that these 
8 patients without tonsillar findings were older than other PTA patients. The fact 
that PTA is encountered also in patients without tonsillar findings suggests that AT 
is not necessarily always a pre-stage of PTA. Patient characteristics, CRP level and 
clinical findings can be used to differentiate PTA patients with different aetiological 
factors causing PTA. [3, 4, 13].  
The growth of GAS and Staphylococcus aureus in bacterial cultures, as well as 
low CRP levels, have been demonstrated earlier in patients with parotitis. Saarinen 
et al. showed that a majority of patients suffering from parotitis had elevated 
S-Amyl levels, but only a few patients demonstrated elevated CRP levels. These 
analogous findings between our eight PTA patients and patients with a confirmed 
infection of major salivary glands support strongly the conclusion that PTA in 
these eight patients is caused by the infection of minor salivary glands. [18, 37-
39]. In our study, the elevation of S-Amyl level in PTA patients without tonsillar 
findings was not significant. One possible explanation is the small size of minor 
salivary glands compared to major salivary glands, which prevents the elevation 
becoming substantial. The S-Amyl reference values are also validated for pancreatic 
diseases, not salivary gland infection, and don´t reflect directly the activity of 
minor salivary glands.
5.5 Saliva bacteria findings
In Study IV, we showed that smoking habits and oral hygiene had no effect on 
the number or distribution of saliva bacteria. Although the role of periodontal 
disease in the development of PTA has been speculated about widely in literature, 
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the association between PTA and periodontal disease has been shown in only one 
study. Georgalas et al. showed that the prevalence of periodontal disease is elevated 
in PTA patients compared to patients with CT. In addition, the overlapping of the 
microbiological profile of these two diseases has been noticed. The pathogenesis 
has, however, stayed unclear; it has even been speculated that perhaps poor oral 
hygiene could be only an indicator of low socioeconomic status, smoking, and the 
patient’s overall health rather than a cause of PTA itself. [3, 12, 172]. 
In our study, we observed no increase in the number of saliva bacteria during 
acute infection compared to the samples of healthy volunteers. This observation 
differs from the Brook et al. study, where they showed a 10- to 1000-fold increase of 
saliva bacteria during AT compared to samples from the same patients after acute 
infection. In the same study, a significant increase in Fusobacterium nucleatum 
antibodies after infection was also noted .[121].  
Smoking has been conclusively shown to be associated with an increased risk to 
PTA in both genders. As many as 30% to 60% of patients with PTA have reported 
daily smoking, which is a significantly higher number than the smoking rate in the 
general population. [36, 46, 48, 49, 66]. Also, the number of ex-smokers among 
PTA patients is high: 18% [49]. The exact mechanism through which smoking 
promotes PTA is, however, unclear. The higher incidence of Streptococcus viridans 
isolates (including SAG) has been reported in smokers suffering from PTA [48]. 
In the other study, however, no differences in PTA pathogens between smokers 
and nonsmokers were reported [46]. 
Effects of smoking on oral microbiota are controversial. In some studies 
smoking have been shown to change the oral microbiota [134, 135]. However, 
opposite findings have also been reported [136]. We observed that smokers had a 
lower number of Fusobacterium nucleatum and ex-smokers had a higher number 
of Streptococcus in their saliva. Our findings differ from Moon et al. and van 
Winkelhoff et al. and their observations that smokers have a higher number of 
Fusobacterium nucleatum in subgingival samples. On the other hand, earlier 
studies analysed only patients with periodontal disease, so the results are not 
completely comparable. [125, 126]. Another mechanism, not related to saliva 
bacteria, has also been speculated upon. Torre et al. have shown histological 
alterations in tonsils´ lymphoid and non-lymphoid compartments in smokers, 
which could reflect that smoking alters the immune responses and predisposes 
smokers to PTAs. Similar, but milder, changes were observed in patients with CT. 
RT is known to predispose to PTA, but no studies about the role of CT are published. 
[35, 36, 67]. On the other hand, an Iranian study group showed that salivary flow 
rate is significantly lower in smokers and this could be the one mechanism of the 
higher rate of oral diseases in smokers [137]. Our findings do not support the 
hypothesis that smoking promotes PTA by changing the oral microbiota.
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5.6 Strengths and Limitations
This thesis consists of four separate studies. Every study has its own limitations, but 
the limitations differ between the studies, which can be regarded as the strength of 
this thesis. The only limitation associated with all our studies is that patients were 
recruited by several of the nurses and physicians in the Emergency Department of 
ORL in HUH and also examined and treated by several physicians. On the other 
hand, this reflects the real circumstances in hospitals and health care centres in 
Finland and makes the results more generalizable. The fact that several physicians 
recruited and examined the patients had the most important impact on results in 
Study III. The evaluation of tonsillar findings (erythema, exudates) was based on 
the ear, nose and throat physician’s subjective observation. Due to the prospective 
nature of the study (physicians had a structured examination form which included 
the questions about the tonsillar findings), as well as the physicians’ substantial 
experience on tonsillar diseases, the evaluation can be considered reliable. 
The microarray assay used in Study I for bacteria determination is non-
standardised. The method is, however, shown to have sufficient accuracy and 
reliability in bacterial identification. [55, 151]. Patients had two different antibiotic 
treatments, which can be considered as a biasing factor but as shown also in the 
original study, it had no effect on recovery or results [55]. The microarray method 
is based on duplicating the bacteria and thus it also observes the dead bacteria, 
whereas the bacterial culture method notices only the living bacteria. In addition, 
because the laboratory´s standard methods for pus samples and throat swabs were 
used, only the colonies large enough to cause disease and bacterial species with 
pathogenic features were answered from cultures. Thus, comparing the bacterial 
findings between the studies in which different methods have been used is not 
completely reliable.
In Study II, the tonsils were collected a mean of six months after the acute 
infection episode which, especially concerning the PTA samples, can be regarded 
as a limitation. Because the specimens were collected originally for another study 
and were not marked during TE, location of the glands in the peritonsillar space 
(i.e. the lower, upper, or middle portions of the peritonsillar space) could not 
be analysed accurately and they could only be classified as deep or superficial. 
Kraitrakul et al. have demonstrated the presence of the minor salivary glands 
in upper, lower and middle portions of peritonsillar space. We were also able to 
observe the minor salivary glands all over the peritonsillar space, supporting the 
findings of Kraitrakul et al. [5].
In Study III, we analysed only the aerobes from throat swabs of AT patients 
which can be considered as a limitation. Bacterial cultures were grown according 
to the laboratory´s standard methods for diagnostic samples. From PTA patients’ 
pus samples both aerobes and anaerobes were analysed, also with the laboratory´s 
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standard methods, and no request to analyse specific bacteria was done. The small 
size of bacterial groups (FN, FN+SAG) also limited the statistical analysis. We 
did not exclude AT patients with earlier PTA (n=3) from the acute group. The 
number of these patients is, however, low (n=3) in our material and we reviewed 
the patient charts and observed no PTA episodes during the few months before 
the current episode. So the influence on results is minor and not significant. The 
evaluation of tonsillar findings (erythema, exudates) was based on subjective 
observation. Evaluation was made by ear, nose and throat physicians, and due to 
the prospective nature of the study as well as the physicians’ large experience of 
tonsillar diseases, the evaluation can be considered reliable. This can, however, 
be considered as a limitation of this study.  The acute group and reference group 
were collected originally for different studies, and in the acute group, we had age 
under 15 years as an exclusion criterion, but in the reference group all patients 
under 18 were excluded. 
In study IV, a physician, not a dentist, evaluated patients´ oral hygiene. No 
standardised evaluation scale or index was used in the dental status. This can 
be regarded as a limitation. In a Georgalas et al. study, periodontal status was 
evaluated by an oral surgeon using the Periodontal Index of Treatment Needs 
(CPITN) [12]. 49 of 200 saliva samples did not become hybridised which means 
that a probe did not recognise any bacteria from the salivary sample. The degree 
of oral hygiene between the different diagnosis groups could not be statistically 
analysed because of the small number of patients with poor oral hygiene in certain 
diagnosis groups. Prior antibiotics had no effect on hybridisation (p=0.348). It 
can be speculated whether previously ingested food or blood blended with saliva 
prevented the hybridisation. None of the healthy volunteers smoked or had alcohol 
abuse, so these parameters could not compare with the patient group.
5.7 Future aspects
The aetiology of PTA and especially the role of minor salivary glands needs to be 
researched more in the future. The histology of tonsillar tissue and minor salivary 
glands should be analysed from the patients who have undergone an abscess 
tonsillectomy. The larger study about the clinical findings of PTA patients—and 
especially the higher sample size of those patients without tonsillar findings— 
and their laboratory results could give us more knowledge about the different 
subgroups of PTA patients. Also, the larger study of PTA patients’ S-Amyl levels 
could strengthen our observations about the amylase levels of PTA patients. 
The development of technology could also make possible finding the markers 
suggesting a greater genetic predisposition to PTA, like certain HLA-molecules 
or from bacteria, like M proteins of GAS. 
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6 CONCLUSIONS
The present studies examined the aetiology of PTA and showed that it is not as 
unambiguous as previously thought. There are various subgroups of PTA patients 
with different patient characteristics, symptoms, and clinical examination findings, 
as well as bacterial and laboratory test results. Some PTA patients´ disease seems 
not to begin as a complication of AT but as an infection of minor salivary glands. 
The renewal rate and severity of the symptoms differ between subgroups. Smoking, 
alcohol consumption, oral hygiene, and acute throat infection have no influence 
on salivary bacteria findings, and the role of periodontal diseases in developing 
PTA is questionable. At least the mechanism seems not to be changes in oral 
microbiota. In the future, more studies about different aetiological factors of PTA 
and, especially, diagnostic tools to differentiate aetiological factors are needed to 
target the treatment, especially TE, more accurately to certain subgroups of PTA 
patients.
The following findings clarify the aetiology of PTA and may act as diagnostic 
tools to separate different aetiological factors:
1. SAG predicts renewal of PTA while GAS is not detected in patients with renewal 
of PTA. 
2. SAG predominates and abscess recurs after a shorter period among male 
patients over 40
3. The minor salivary glands are identified in peritonsillar space in PTA patients 
and the histological signs of peritonsillar inflammation are more intense than 
in patients with AT or CT.
4. Not all patients with PTA have signs of infection in tonsils in clinical 
examination. These patients have significantly lower CRP levels than other 
PTA patients
5. A negative correlation between CRP and S-Amyl levels is observed during the 
acute infection. In post-infectious condition, correlation is not noted.
6. Smoking, oral hygiene, and acute throat infection (AT, PT, PTA) have no 
influence on the number of saliva bacteria.
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